Gene_set	Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
GWAS_Catalog_2019	Large artery stroke	3/7	0.00014436477116005187	0.2507616075050101	0	0	26.212319790301443	231.79992996870243	TTLL5;HDAC9;SUPT3H
GWAS_Catalog_2019	Pulse pressure	22/567	0.00017567487986253603	0.15257363316061254	0	0	2.3731318328667967	20.520175610079587	FHOD3;COG5;FAF1;FBXL17;PTEN;PRKAG2;SLAIN2;MSI2;AIG1;HDAC9;ARHGAP24;KIF15;FER;ZEB1;FGGY;NDUFAF6;ZNF618;PRKD3;UBAP1;KCNQ5;SRFBP1;MAP4
GWAS_Catalog_2019	Male-pattern baldness	13/251	0.0002663438728817241	0.15421310239851824	0	0	3.1677571061320466	26.07292914589875	FEN1;USP37;FAF1;MEMO1;MSI2;HDAC9;SUPT3H;TTC27;KATNAL1;TRPS1;DIP2B;TRMT11;LGR4
GWAS_Catalog_2019	Asthma	11/204	0.0005580906543311046	0.24235086664328215	0	0	3.2979552677340047	24.704947113994244	FER;BMPER;KIF16B;ERCC4;TRPS1;VPS13C;CDHR3;BBS9;AAGAB;SAMD12;PRKG1
GWAS_Catalog_2019	Systolic blood pressure	22/657	0.0012612047934081464	0.4381425452299902	0	0	2.0480452804192906	13.672110953022324	BCAR3;YES1;SYT1;EXOC6B;PRKAG2;DDX10;SLAIN2;CWC27;HDAC9;ARHGAP24;RTN4;TTC28;FER;PRKD3;SRFBP1;WDR7;MAP4;DIP2B;ZFPM2;LCORL;METTL15;XPR1
GWAS_Catalog_2019	Major depressive disorder	10/212	0.0026569897650555816	0.7691985369835909	0	0	2.8850037505048762	17.109692067046858	BCAR3;RERE;NLGN1;PARD3;TRPS1;RASA1;ZNF326;VRK2;RGS7;RBMS3
GWAS_Catalog_2019	Periodontal disease-related phenotypes	4/38	0.0033415347866425594	0.8291779891997323	0	0	6.438113632705617	36.70577859700797	FHOD3;ATL1;MAP4K5;RBMS3
GWAS_Catalog_2019	Bone mineral density	6/89	0.003401946038105967	0.7386475335237581	0	0	4.123286259148541	23.43431665580493	RERE;RPS6KA5;ERC1;SUPT3H;LGR4;RBMS3
GWAS_Catalog_2019	Sodium levels	3/19	0.003455340542759986	0.6668807247526775	0	0	9.657170449058425	54.735241539560356	SYT1;NAV3;CEP83
GWAS_Catalog_2019	Blood pressure measurement (low sodium intervention)	2/6	0.0038275922577605133	0.664852775173001	0	0	20.387359836901123	113.46624519472326	IRAK1BP1;PIBF1
GWAS_Catalog_2019	Depression and alcohol dependence	2/6	0.0038275922577605133	0.6044116137936373	0	0	20.387359836901123	113.46624519472326	FAF1;WDR7
GWAS_Catalog_2019	Egg allergy	2/6	0.0038275922577605133	0.5540439793108342	0	0	20.387359836901123	113.46624519472326	SGCD;ERCC4
GWAS_Catalog_2019	Memory dysfunction in frontotemporal lobe dementia	2/6	0.0038275922577605133	0.5114252116715392	0	0	20.387359836901123	113.46624519472326	FUT10;MAGI2
GWAS_Catalog_2019	Hand grip strength	8/156	0.004208779954640777	0.5221893415150736	0	0	3.136516897984788	17.158574359866858	NLGN1;SYT1;TRPS1;CADPS;FBXL17;SMARCAD1;LCORL;OPCML
GWAS_Catalog_2019	Central corneal thickness	5/66	0.004484395443146853	0.5192929923164056	0	0	4.633490872022982	25.053987525910763	RABGEF1;STAG1;NDUFAF6;CWC27;ADAMTS6
GWAS_Catalog_2019	Serum metabolite ratios in chronic kidney disease	3/21	0.004629569206522529	0.5025976069831021	0	0	8.73743993010048	46.96628623119675	FEN1;ACADM;SGPP1
GWAS_Catalog_2019	Familial squamous cell lung carcinoma	4/43	0.005241486142692093	0.5355565546974214	0	0	5.6894957684375225	29.876396875572144	GPD2;DCUN1D4;LCORL;EZH2
GWAS_Catalog_2019	Stroke (ischemic)	2/7	0.005300890354648662	0.5115359192235959	0	0	17.47487986020096	91.566281888858	HDAC9;SUPT3H
GWAS_Catalog_2019	Chloride levels	3/24	0.006795399390794502	0.6212425653584237	0	0	7.64525993883792	38.161387277885865	SYT1;NAV3;CEP83
GWAS_Catalog_2019	Tuberculosis (SNP x SNP interaction)	3/24	0.006795399390794502	0.5901804370905025	0	0	7.64525993883792	38.161387277885865	DIAPH2;SYT1;GPC6
GWAS_Catalog_2019	Obesity-related traits	23/804	0.0069205261393783715	0.5724263763857252	0	0	1.7496614785400215	8.701527534532017	FHOD3;SPECC1;SYT1;MAGI3;CEP152;PRDM5;IREB2;MAGI2;NUP153;CWC27;HDAC9;SUPT3H;ARHGAP24;TTLL7;SDK1;ABLIM1;FUT8;FGGY;SGCD;GPC6;METTL15;PRKG1;RGS7
GWAS_Catalog_2019	Post bronchodilator FEV1/FVC ratio	9/206	0.0069832661001012295	0.5513606007216288	0	0	2.6721296873608265	13.265089201921034	FUT8;USP37;GNG2;MSH2;KIF16B;RUVBL1;IREB2;EDIL3;SUPT3H
GWAS_Catalog_2019	Multiple sclerosis (age of onset)	2/8	0.0069917989818407454	0.5280328187590162	0	0	15.290519877675841	75.88711606695597	SGCD;WDR7
GWAS_Catalog_2019	Smoking cessation in chronic obstructive pulmonary disease	2/8	0.0069917989818407454	0.5060314513107239	0	0	15.290519877675841	75.88711606695597	VEPH1;CDHR3
GWAS_Catalog_2019	Epilepsy	2/8	0.0069917989818407454	0.4857901932582949	0	0	15.290519877675841	75.88711606695597	FANCL;VRK2
GWAS_Catalog_2019	Urate levels in obese individuals	4/47	0.0071996908009857655	0.4809947277427797	0	0	5.205283362613051	25.681396047575213	STAU2;UBE2Q2;KCNS3;LGR4
GWAS_Catalog_2019	Severe influenza A (H1N1) infection	4/48	0.00775506725663041	0.4989093268432229	0	0	5.096839959225281	24.76762899954958	RIC8B;FANCM;TRPS1;KIF15
GWAS_Catalog_2019	Asthma (childhood onset)	4/52	0.010256075746064948	0.6362429846755291	0	0	4.704775346977182	21.54733000844197	FER;ERCC4;CDHR3;XPR1
GWAS_Catalog_2019	Colorectal or endometrial cancer	3/29	0.011553686318780171	0.6920259701972811	0	0	6.3271116735210375	28.223668023641117	RNGTT;GMCL1;EZH2
GWAS_Catalog_2019	Coronary artery calcification	4/55	0.012439019866913944	0.7202192502943173	0	0	4.4481512371420635	19.513670207877194	PRICKLE2;MSI2;ZFPM2;WDR33
GWAS_Catalog_2019	Upper eyelid sagging severity	2/11	0.013296451214537557	0.7450301857952172	0	0	11.120378092855155	48.04290359002983	KCNQ5;TTC27
GWAS_Catalog_2019	Macular thickness	8/191	0.013534233542052144	0.7346551144545179	0	0	2.5617624925949056	11.022067625071076	ARHGAP22;INVS;IRAK1BP1;NDUFAF6;COG5;RASA1;SKAP2;RBMS3
GWAS_Catalog_2019	Diverticular disease	7/156	0.014421335714454643	0.7590866707881128	0	0	2.7444522857366893	11.633860916972894	WDR70;TRPS1;CENPK;ADK;CWC27;LCORL;OPCML
GWAS_Catalog_2019	Waist-hip ratio	4/58	0.014898517501157787	0.7611389676326787	0	0	4.218074449014025	17.743303037213657	ZEB1;FANCL;GPC6;OPCML
GWAS_Catalog_2019	Motion sickness	3/32	0.015130589453502841	0.7509095394495552	0	0	5.73394495412844	24.03117426999677	SDK1;NLGN1;GPD2
GWAS_Catalog_2019	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes	3/32	0.015130589453502841	0.730050941131512	0	0	5.73394495412844	24.03117426999677	MAGI2;STARD9;PDSS2
GWAS_Catalog_2019	Alzheimer's disease progression score	2/12	0.015784972363794326	0.741040459348939	0	0	10.193679918450561	42.29048835639957	BCAR3;LCORL
GWAS_Catalog_2019	Osteoarthritis	2/12	0.015784972363794326	0.7215393946292301	0	0	10.193679918450561	42.29048835639957	COG5;SUPT3H
GWAS_Catalog_2019	Triptolide cytotoxicity	2/12	0.015784972363794326	0.7030383845105319	0	0	10.193679918450561	42.29048835639957	ORC2;FAM126B
GWAS_Catalog_2019	Gastric cancer	2/12	0.015784972363794326	0.6854624248977685	0	0	10.193679918450561	42.29048835639957	PRKAA1;OPCML
GWAS_Catalog_2019	Waist circumference adjusted for BMI in smokers	2/12	0.015784972363794326	0.6687438291685547	0	0	10.193679918450561	42.29048835639957	FER;LCORL
GWAS_Catalog_2019	Colorectal cancer	6/124	0.016326541355657316	0.6752191032089704	0	0	2.959455460195324	12.178050285264995	SLC25A26;FEN1;KCNS3;NAF1;GOPC;DIP2B
GWAS_Catalog_2019	Blood pressure (smoking interaction)	3/33	0.016446175878944248	0.6643490116680503	0	0	5.5601890464275785	22.83937891665854	SACS;GPC6;OPCML
GWAS_Catalog_2019	Irritable mood	3/33	0.016446175878944248	0.6492501704937763	0	0	5.5601890464275785	22.83937891665854	FANCL;FBXL17;VRK2
GWAS_Catalog_2019	Loneliness (multivariate analysis)	3/33	0.016446175878944248	0.6348223889272478	0	0	5.5601890464275785	22.83937891665854	PRDM5;UTRN;PRKG1
GWAS_Catalog_2019	Post bronchodilator FEV1	6/126	0.01753240212310586	0.662038749735541	0	0	2.91247997670016	11.777208563176027	BMPER;KCNT2;GSTCD;RUVBL1;IREB2;RGS7
GWAS_Catalog_2019	Serum metabolite concentrations in chronic kidney disease	3/34	0.017823914170976632	0.6587263598933278	0	0	5.396654074473827	21.733482086408415	ZNF618;ACADM;SGPP1
GWAS_Catalog_2019	Feeling miserable	3/34	0.017823914170976632	0.6450028940622169	0	0	5.396654074473827	21.733482086408415	RERE;FANCL;VRK2
GWAS_Catalog_2019	Airway responsiveness in chronic obstructive pulmonary disease	2/13	0.0184555827281209	0.6542315754846123	0	0	9.409550693954364	37.566580732775904	SGCD;PDSS2
GWAS_Catalog_2019	QT interval (sulfonylurea treatment interaction)	2/13	0.0184555827281209	0.6411469439749201	0	0	9.409550693954364	37.566580732775904	KCNS3;CADPS
GWAS_Catalog_2019	Night sleep phenotypes	16/555	0.020901125218589268	0.7118677353860697	0	0	1.763231121029286	6.820093840483713	MAGI2;HDAC9;IMMP2L;FRAS1;RIC8B;NUDCD1;ERCC4;TRPS1;MYO18A;POC1B;RTTN;GOPC;TNIK;C3ORF67;GPC6;RBMS3
GWAS_Catalog_2019	Ischemic stroke (large artery atherosclerosis)	2/14	0.021301700618819443	0.7115587302863341	0	0	8.73743993010048	33.630129909958704	FAF1;HDAC9
GWAS_Catalog_2019	Photic sneeze reflex	4/65	0.02176830791927852	0.7134254878450338	0	0	3.7638202775817455	14.405269845587965	KCNT2;GPATCH2;EDIL3;CDC73
GWAS_Catalog_2019	HIV-1 viral setpoint	3/37	0.02233174294963456	0.7183377315465782	0	0	4.9590875278948685	18.85319197622273	GALNT14;SGCD;KCNQ5
GWAS_Catalog_2019	Acute lymphoblastic leukemia (childhood)	3/38	0.0239594782923228	0.7566838871593583	0	0	4.8285852245292125	18.01734080194116	PARD3;MAGI2;AIG1
GWAS_Catalog_2019	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes	3/38	0.0239594782923228	0.7431716748886554	0	0	4.8285852245292125	18.01734080194116	NAV3;MAGI2;AGAP1
GWAS_Catalog_2019	Self-rated health	2/15	0.024316909730482842	0.7410258281026088	0	0	8.154943934760448	30.308528415584412	NAV3;SAMD12
GWAS_Catalog_2019	Urinary albumin-to-creatinine ratio	2/15	0.024316909730482842	0.7282495207215294	0	0	8.154943934760448	30.308528415584412	LYPLA1;RGS20
GWAS_Catalog_2019	Hair morphology	2/15	0.024316909730482842	0.7159063085059102	0	0	8.154943934760448	30.308528415584412	FRAS1;NAF1
GWAS_Catalog_2019	Hirschsprung disease	2/15	0.024316909730482842	0.7039745366974783	0	0	8.154943934760448	30.308528415584412	FANCL;VRK2
GWAS_Catalog_2019	Endometrial cancer (endometrioid histology)	3/39	0.025649756414765485	0.7303873261056991	0	0	4.704775346977182	17.234632810683706	FCHSD2;NAV3;RUVBL1
GWAS_Catalog_2019	Depression	4/69	0.02643450864262143	0.740592605036023	0	0	3.5456277977219344	12.881567085394769	RERE;GPD2;MYO18A;VRK2
GWAS_Catalog_2019	Resting-state electroencephalogram vigilance	3/42	0.031094638511097845	0.8573236046631264	0	0	4.36871996505024	15.16260318829291	SGCD;MEOX2;HDAC9
GWAS_Catalog_2019	Obsessive-compulsive symptoms	2/18	0.0343153267032211	0.9313394138046102	0	0	6.7957866123003745	22.916501406423286	CADPS;ZNF326
GWAS_Catalog_2019	Logical memory (delayed recall) in mild cognitive impairment	2/19	0.03794592030406145	1.0	0	0	6.438113632705617	21.062889314588773	NLN;ARHGAP24
GWAS_Catalog_2019	Ankylosing spondylitis	3/47	0.04140176163742077	1.0	0	0	3.9039625219597887	12.431902586092686	UBE2E3;LNPEP;EDIL3
GWAS_Catalog_2019	Anorexia nervosa	3/47	0.04140176163742077	1.0	0	0	3.9039625219597887	12.431902586092686	NTNG1;CEP350;SSBP2
GWAS_Catalog_2019	Chronic obstructive pulmonary disease	3/47	0.04140176163742077	1.0	0	0	3.9039625219597887	12.431902586092686	GNG2;GSTCD;IREB2
GWAS_Catalog_2019	Cerebrospinal P-tau181p levels	3/48	0.04364487774006379	1.0	0	0	3.82262996941896	11.971213119398096	MTBP;URI1;TTC28
GWAS_Catalog_2019	Lung function (FEV1/FVC)	4/81	0.043794029703142535	1.0	0	0	3.0203496054668326	9.448432148715872	KCNS3;CADPS;KCNQ5;RBMS3
GWAS_Catalog_2019	Atrial fibrillation	8/240	0.04429038984260192	1.0	0	0	2.038735983690112	6.354714697329492	SLC25A26;HERC1;FAM13B;COG5;FAF1;GOPC;MLLT3;GMCL1
GWAS_Catalog_2019	Type 1 diabetes and autoimmune thyroid diseases	2/21	0.0456197091896029	1.0	0	0	5.82495995340032	17.98407127870286	MAGI3;TAP2
GWAS_Catalog_2019	Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)	2/23	0.053807688438807434	1.0	0	0	5.318441696582902	15.54228913304198	PRIM2;FEN1
GWAS_Catalog_2019	Western dietary pattern	2/23	0.053807688438807434	1.0	0	0	5.318441696582902	15.54228913304198	KCNQ5;RGS7
GWAS_Catalog_2019	Schizophrenia	21/882	0.05531244200541596	1.0	0	0	1.45623998835008	4.215461489302743	SPECC1;RERE;FANCL;VPS13C;IREB2;MAGI2;VRK2;MSI2;DCAF6;STAG1;IMMP2L;PRKD3;ATXN7;TBC1D5;ERCC4;PARD3;ZSCAN23;PRKG1;ADAMTS6;RBMS3;POLG
GWAS_Catalog_2019	Takayasu arteritis	4/88	0.05627498325002199	1.0	0	0	2.780094523213789	7.999736418778109	KCNT2;ZFPM2;CDC73;OPCML
GWAS_Catalog_2019	Cerebrospinal fluid clusterin levels	2/24	0.058081539079494884	1.0	0	0	5.096839959225281	14.50513460506676	SETD5;MAGI3
GWAS_Catalog_2019	QRS duration	3/55	0.06098202956598344	1.0	0	0	3.3361134278565467	9.331696598799294	FHOD3;SLC25A26;FAF1
GWAS_Catalog_2019	Inflammatory biomarkers	2/25	0.06246865312124018	1.0	0	0	4.892966360856269	13.56863803360607	APBB1IP;COMMD10
GWAS_Catalog_2019	Sleep duration	3/56	0.06368511436137668	1.0	0	0	3.2765399737876804	9.022950285737656	VRK2;NAALADL2;RAD18
GWAS_Catalog_2019	Dupuytren's disease	3/56	0.06368511436137668	1.0	0	0	3.2765399737876804	9.022950285737656	SDK1;ATL1;MAP4K5
GWAS_Catalog_2019	Breast size	4/93	0.06623944315116208	1.0	0	0	2.6306270757291768	7.1407824155071715	VPS13C;CADPS;GPC6;RBMS3
GWAS_Catalog_2019	Intraocular pressure	11/401	0.06641292828332744	1.0	0	0	1.6777627795953538	4.549863708052112	STAG1;FER;NDUFAF6;SCFD2;VPS13C;FBXL17;BBS9;PRKAG2;SUPT3H;ADAMTS6;MIPOL1
GWAS_Catalog_2019	Aortic root size	2/26	0.06696421009998317	1.0	0	0	4.704775346977182	12.719816419322758	RABGEF1;FGGY
GWAS_Catalog_2019	Erosive tooth wear (severe vs none or mild)	2/26	0.06696421009998317	1.0	0	0	4.704775346977182	12.719816419322758	FUT8;SKAP2
GWAS_Catalog_2019	Daytime sleep phenotypes	8/263	0.06810657200604213	1.0	0	0	1.8604434832153116	4.998419209552959	ARHGAP22;MAPK8;PLCB4;SGCD;NUDCD1;ACADM;AIG1;C3ORF67
GWAS_Catalog_2019	White blood cell count (basophil)	4/95	0.07046552204461594	1.0	0	0	2.575245453082247	6.8311778214709165	APBB1IP;PTEN;LARP4B;ZFPM2
GWAS_Catalog_2019	Seasonality and depression	2/27	0.07156351602310844	1.0	0	0	4.530524408200249	11.947762544485398	FGGY;ADAMTS12
GWAS_Catalog_2019	Survival in pancreatic cancer	2/27	0.07156351602310844	1.0	0	0	4.530524408200249	11.947762544485398	ZNF207;LGR4
GWAS_Catalog_2019	Disease progression in age-related macular degeneration	4/97	0.07482665525154457	1.0	0	0	2.5221476086887984	6.5388722314078125	SDK1;HERC1;METTL4;BBS9
GWAS_Catalog_2019	Multiple sclerosis--Brain Glutamate Levels	1/5	0.07912749420053085	1.0	0	0	12.232415902140673	31.029906749027802	FUT8
GWAS_Catalog_2019	Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	1/5	0.07912749420053085	1.0	0	0	12.232415902140673	31.029906749027802	HDAC9
GWAS_Catalog_2019	Autism spectrum disorder	1/5	0.07912749420053085	1.0	0	0	12.232415902140673	31.029906749027802	NAALADL2
GWAS_Catalog_2019	Binge eating behaviour and bipolar disorder	1/5	0.07912749420053085	1.0	0	0	12.232415902140673	31.029906749027802	SLC25A26
GWAS_Catalog_2019	Birdshot chorioretinopathy	1/5	0.07912749420053085	1.0	0	0	12.232415902140673	31.029906749027802	LNPEP
GWAS_Catalog_2019	Pulmonary artery enlargement and chronic obstructive pulmonary disease	1/5	0.07912749420053085	1.0	0	0	12.232415902140673	31.029906749027802	IREB2
GWAS_Catalog_2019	Cervical artery dissection	1/5	0.07912749420053085	1.0	0	0	12.232415902140673	31.029906749027802	FGGY
GWAS_Catalog_2019	Conduct disorder	1/5	0.07912749420053085	1.0	0	0	12.232415902140673	31.029906749027802	ARHGAP22
GWAS_Catalog_2019	Suffering from nerves	1/5	0.07912749420053085	1.0	0	0	12.232415902140673	31.029906749027802	ACYP1
GWAS_Catalog_2019	Suicide behavior	1/5	0.07912749420053085	1.0	0	0	12.232415902140673	31.029906749027802	STK3
GWAS_Catalog_2019	Thiopurine-induced leukopenia in inflammatory bowel disease	1/5	0.07912749420053085	1.0	0	0	12.232415902140673	31.029906749027802	CADPS
GWAS_Catalog_2019	Two-hour glucose challenge	1/5	0.07912749420053085	1.0	0	0	12.232415902140673	31.029906749027802	VPS13C
GWAS_Catalog_2019	Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	1/5	0.07912749420053085	1.0	0	0	12.232415902140673	31.029906749027802	NDUFAF6
GWAS_Catalog_2019	Whole-brain volume (Alzheimer's disease interaction)	1/5	0.07912749420053085	1.0	0	0	12.232415902140673	31.029906749027802	BIRC3
GWAS_Catalog_2019	facial morphology traits (multivariate analysis)	1/5	0.07912749420053085	1.0	0	0	12.232415902140673	31.029906749027802	SUPT3H
GWAS_Catalog_2019	middle facial morphology traits (quantitative measurement)	1/5	0.07912749420053085	1.0	0	0	12.232415902140673	31.029906749027802	SUPT3H
GWAS_Catalog_2019	Hepatocellular carcinoma in hepatitis B infection	1/5	0.07912749420053085	1.0	0	0	12.232415902140673	31.029906749027802	VEPH1
GWAS_Catalog_2019	Iris characteristics	1/5	0.07912749420053085	1.0	0	0	12.232415902140673	31.029906749027802	HERC1
GWAS_Catalog_2019	Left ventricular obstructive tract defect (maternal effect)	1/5	0.07912749420053085	1.0	0	0	12.232415902140673	31.029906749027802	FRAS1
GWAS_Catalog_2019	Liver fibrosis in pediatric non-alcoholic fatty acid liver disease	1/5	0.07912749420053085	1.0	0	0	12.232415902140673	31.029906749027802	SDK1
GWAS_Catalog_2019	Lung cancer (smoking interaction)	1/5	0.07912749420053085	1.0	0	0	12.232415902140673	31.029906749027802	GNG2
GWAS_Catalog_2019	Tonsillectomy	3/62	0.0810235856967713	1.0	0	0	2.959455460195324	7.437155919660152	RERE;ADAM23;MIPOL1
GWAS_Catalog_2019	Metabolite levels  (X-11787)	2/29	0.08105521428533359	1.0	0	0	4.218074449014025	10.598438041502716	COMMD10;CADPS
GWAS_Catalog_2019	Bilirubin levels	2/31	0.0909086198991798	1.0	0	0	3.945940613593765	9.461972788481068	ERCC4;USP40
GWAS_Catalog_2019	Height	13/527	0.09349772268812176	1.0	0	0	1.508741999315263	3.575444247966568	NUP153;FANCC;SUPT3H;ARHGAP24;NAALADL2;STAG1;TTLL5;FER;ERC1;LCORL;CLOCK;EZH2;POLG
GWAS_Catalog_2019	Osteosarcoma	1/6	0.09418749802372978	1.0	0	0	10.193679918450561	24.08224081118982	ADAMTS6
GWAS_Catalog_2019	Blood pressure measurement (high sodium and potassium intervention)	1/6	0.09418749802372978	1.0	0	0	10.193679918450561	24.08224081118982	IRAK1BP1
GWAS_Catalog_2019	Blood pressure measurement (high sodium intervention)	1/6	0.09418749802372978	1.0	0	0	10.193679918450561	24.08224081118982	IRAK1BP1
GWAS_Catalog_2019	Possible neuropathic pain in post total joint replacement surgery for osteoarthritis	1/6	0.09418749802372978	1.0	0	0	10.193679918450561	24.08224081118982	GPD2
GWAS_Catalog_2019	Psychosis proneness (hypomanic personality scale and revised physical anhedonia scale)	1/6	0.09418749802372978	1.0	0	0	10.193679918450561	24.08224081118982	TRMT11
GWAS_Catalog_2019	Remission after SSRI treatment in MDD or openness	1/6	0.09418749802372978	1.0	0	0	10.193679918450561	24.08224081118982	UTRN
GWAS_Catalog_2019	Response to SSRI in MDD or openness	1/6	0.09418749802372978	1.0	0	0	10.193679918450561	24.08224081118982	UTRN
GWAS_Catalog_2019	Chlamydia trachomatis seropositivity	1/6	0.09418749802372978	1.0	0	0	10.193679918450561	24.08224081118982	PRKG1
GWAS_Catalog_2019	Conduct disorder (symptom count)	1/6	0.09418749802372978	1.0	0	0	10.193679918450561	24.08224081118982	ERCC4
GWAS_Catalog_2019	Delta-5 desaturase activity response to n3-polyunsaturated fat supplement	1/6	0.09418749802372978	1.0	0	0	10.193679918450561	24.08224081118982	FEN1
GWAS_Catalog_2019	Sleep traits (multi-trait analysis)	1/6	0.09418749802372978	1.0	0	0	10.193679918450561	24.08224081118982	PATJ
GWAS_Catalog_2019	Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection	1/6	0.09418749802372978	1.0	0	0	10.193679918450561	24.08224081118982	TTLL7
GWAS_Catalog_2019	Longitudinal alcohol consumption	1/6	0.09418749802372978	1.0	0	0	10.193679918450561	24.08224081118982	MIPOL1
GWAS_Catalog_2019	Bipolar disorder and schizophrenia	2/32	0.0959604933110234	1.0	0	0	3.82262996941896	8.959551606366071	COMMD10;ADAM23
GWAS_Catalog_2019	Hippocampal atrophy	2/32	0.0959604933110234	1.0	0	0	3.82262996941896	8.959551606366071	MAGI2;TTC27
GWAS_Catalog_2019	Periodontal microbiota	2/34	0.10629461687673963	1.0	0	0	3.5977693829825514	8.064546270102692	UHRF2;TRPS1
GWAS_Catalog_2019	Myopia	3/70	0.10690467934143097	1.0	0	0	2.6212319790301444	5.8605968252603695	NT5DC1;GPD2;KCNQ5
GWAS_Catalog_2019	Non-cardia gastric cancer	1/7	0.1090019523467562	1.0	0	0	8.73743993010048	19.36556999104649	PRKAA1
GWAS_Catalog_2019	Non-response to bupropion and depression	1/7	0.1090019523467562	1.0	0	0	8.73743993010048	19.36556999104649	ADAMTS6
GWAS_Catalog_2019	Number of children ever born	1/7	0.1090019523467562	1.0	0	0	8.73743993010048	19.36556999104649	FBXL17
GWAS_Catalog_2019	Bacteremia	1/7	0.1090019523467562	1.0	0	0	8.73743993010048	19.36556999104649	MAGI3
GWAS_Catalog_2019	Birth length	1/7	0.1090019523467562	1.0	0	0	8.73743993010048	19.36556999104649	LCORL
GWAS_Catalog_2019	Pneumococcal bacteremia	1/7	0.1090019523467562	1.0	0	0	8.73743993010048	19.36556999104649	DOCK2
GWAS_Catalog_2019	Pulmonary function in asthmatics	1/7	0.1090019523467562	1.0	0	0	8.73743993010048	19.36556999104649	YES1
GWAS_Catalog_2019	Chemerin levels	1/7	0.1090019523467562	1.0	0	0	8.73743993010048	19.36556999104649	EDIL3
GWAS_Catalog_2019	Childhood and early adolescence aggressive behavior	1/7	0.1090019523467562	1.0	0	0	8.73743993010048	19.36556999104649	PDSS2
GWAS_Catalog_2019	Response to antidepressants and depression	1/7	0.1090019523467562	1.0	0	0	8.73743993010048	19.36556999104649	NDC1
GWAS_Catalog_2019	Response to antipsychotic therapy (extrapyramidal side effects)	1/7	0.1090019523467562	1.0	0	0	8.73743993010048	19.36556999104649	FGGY
GWAS_Catalog_2019	Response to antipsychotic treatment in schizophrenia	1/7	0.1090019523467562	1.0	0	0	8.73743993010048	19.36556999104649	TNIK
GWAS_Catalog_2019	Response to lithium treatment in bipolar disorder	1/7	0.1090019523467562	1.0	0	0	8.73743993010048	19.36556999104649	HDAC9
GWAS_Catalog_2019	Decline in glucose metabolism in posterior cingulate cortex	1/7	0.1090019523467562	1.0	0	0	8.73743993010048	19.36556999104649	TYW1
GWAS_Catalog_2019	Serum urate levels in chronic kidney disease	1/7	0.1090019523467562	1.0	0	0	8.73743993010048	19.36556999104649	URI1
GWAS_Catalog_2019	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	1/7	0.1090019523467562	1.0	0	0	8.73743993010048	19.36556999104649	OPCML
GWAS_Catalog_2019	Suicide in bipolar disorder	1/7	0.1090019523467562	1.0	0	0	8.73743993010048	19.36556999104649	CCDC7
GWAS_Catalog_2019	Emphysema-related traits	1/7	0.1090019523467562	1.0	0	0	8.73743993010048	19.36556999104649	PARD3
GWAS_Catalog_2019	Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease	1/7	0.1090019523467562	1.0	0	0	8.73743993010048	19.36556999104649	MNAT1
GWAS_Catalog_2019	Exploratory eye movement dysfunction in schizophrenia (responsive search score)	1/7	0.1090019523467562	1.0	0	0	8.73743993010048	19.36556999104649	TAF8
GWAS_Catalog_2019	Hippocampal volume in normal cognition	1/7	0.1090019523467562	1.0	0	0	8.73743993010048	19.36556999104649	RERE
GWAS_Catalog_2019	Influenza A (H1N1) severity	1/7	0.1090019523467562	1.0	0	0	8.73743993010048	19.36556999104649	NAALADL2
GWAS_Catalog_2019	Lifetime average cigarettes per day in chronic obstructive pulmonary disease	1/7	0.1090019523467562	1.0	0	0	8.73743993010048	19.36556999104649	SCFD2
GWAS_Catalog_2019	MGMT methylation in smokers	1/7	0.1090019523467562	1.0	0	0	8.73743993010048	19.36556999104649	STARD9
GWAS_Catalog_2019	Middle childhood and early adolescence aggressive behavior	1/7	0.1090019523467562	1.0	0	0	8.73743993010048	19.36556999104649	OPCML
GWAS_Catalog_2019	Diastolic blood pressure	15/646	0.11061302856705796	1.0	0	0	1.420172124861533	3.1268176752532644	RERE;URI1;YES1;CLPB;RTKN2;GPATCH2;EXOC6B;PRKAG2;PRKD3;ATXN7;MAP4;DIP2B;METTL15;RGS7;RBMS3
GWAS_Catalog_2019	Chronic obstructive pulmonary disease-related biomarkers	2/36	0.116910537614389	1.0	0	0	3.3978933061501873	7.293055631810644	FUT8;OPCML
GWAS_Catalog_2019	Emphysema imaging phenotypes	2/36	0.116910537614389	1.0	0	0	3.3978933061501873	7.293055631810644	KIF16B;ERCC4
GWAS_Catalog_2019	Total body bone mineral density	2/36	0.116910537614389	1.0	0	0	3.3978933061501873	7.293055631810644	RERE;KCNQ5
GWAS_Catalog_2019	Glomerular filtration rate in non diabetics (creatinine)	2/37	0.12231504397731326	1.0	0	0	3.306058351929912	6.946541813522433	UBE2Q2;PRKAG2
GWAS_Catalog_2019	Adverse response to chemotherapy in breast cancer (alopecia) (FDC/DC)	1/8	0.12357484815180213	1.0	0	0	7.64525993883792	15.985537068682735	LCORL
GWAS_Catalog_2019	Neuroblastoma	1/8	0.12357484815180213	1.0	0	0	7.64525993883792	15.985537068682735	BARD1
GWAS_Catalog_2019	Bipolar disorder lithium response (categorical) or schizophrenia	1/8	0.12357484815180213	1.0	0	0	7.64525993883792	15.985537068682735	ERCC4
GWAS_Catalog_2019	Placental abruption	1/8	0.12357484815180213	1.0	0	0	7.64525993883792	15.985537068682735	DOCK2
GWAS_Catalog_2019	Body mass index and waist-hip ratio (pleiotropy)	1/8	0.12357484815180213	1.0	0	0	7.64525993883792	15.985537068682735	DOCK2
GWAS_Catalog_2019	Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)	1/8	0.12357484815180213	1.0	0	0	7.64525993883792	15.985537068682735	TNIK
GWAS_Catalog_2019	Capecitabine sensitivity	1/8	0.12357484815180213	1.0	0	0	7.64525993883792	15.985537068682735	SMARCAD1
GWAS_Catalog_2019	Renal sinus fat	1/8	0.12357484815180213	1.0	0	0	7.64525993883792	15.985537068682735	GPC6
GWAS_Catalog_2019	Chronic central serous retinopathy	1/8	0.12357484815180213	1.0	0	0	7.64525993883792	15.985537068682735	ARFGEF1
GWAS_Catalog_2019	Response to bupropion and depression	1/8	0.12357484815180213	1.0	0	0	7.64525993883792	15.985537068682735	NAV3
GWAS_Catalog_2019	Clopidogrel active metabolite levels	1/8	0.12357484815180213	1.0	0	0	7.64525993883792	15.985537068682735	RAD18
GWAS_Catalog_2019	Response to selective serotonin reuptake inhibitors and depression	1/8	0.12357484815180213	1.0	0	0	7.64525993883792	15.985537068682735	FANCL
GWAS_Catalog_2019	Current cigarettes per day in chronic obstructive pulmonary disease	1/8	0.12357484815180213	1.0	0	0	7.64525993883792	15.985537068682735	IREB2
GWAS_Catalog_2019	Soluble interleukin-2 receptor subunit alpha	1/8	0.12357484815180213	1.0	0	0	7.64525993883792	15.985537068682735	ADK
GWAS_Catalog_2019	Dimensional psychopathology (Positive)	1/8	0.12357484815180213	1.0	0	0	7.64525993883792	15.985537068682735	KIF16B
GWAS_Catalog_2019	Emphysema distribution in smoking	1/8	0.12357484815180213	1.0	0	0	7.64525993883792	15.985537068682735	IREB2
GWAS_Catalog_2019	Total ventricular volume	1/8	0.12357484815180213	1.0	0	0	7.64525993883792	15.985537068682735	KCNT2
GWAS_Catalog_2019	Frontotemporal dementia (age at onset)	1/8	0.12357484815180213	1.0	0	0	7.64525993883792	15.985537068682735	TNIK
GWAS_Catalog_2019	Hippocampal tail volume (corrected for total hippocampal volume)	1/8	0.12357484815180213	1.0	0	0	7.64525993883792	15.985537068682735	FAF1
GWAS_Catalog_2019	Dental caries	3/75	0.12450732893835875	1.0	0	0	2.4464831804281344	5.096980300514245	NT5DC1;SCN9A;RBMS3
GWAS_Catalog_2019	QT interval	4/117	0.12540867978545392	1.0	0	0	2.0910112653231923	4.3413104082987735	FRAS1;UBE2E3;SMARCAD1;ARHGAP24
GWAS_Catalog_2019	Itch intensity from mosquito bite adjusted by bite size	4/117	0.12540867978545392	1.0	0	0	2.0910112653231923	4.3413104082987735	LYPLA1;FRAS1;MAGI2;RAPGEF6
GWAS_Catalog_2019	Experiencing mood swings	2/38	0.1277792457106232	1.0	0	0	3.2190568163528086	6.623052138602782	FBXL17;VRK2
GWAS_Catalog_2019	Glaucoma (primary open-angle)	3/76	0.12814700750785402	1.0	0	0	2.4142926122646062	4.960350501990782	VPS13C;PRKAG2;ZFPM2
GWAS_Catalog_2019	Nasopharyngeal carcinoma (SNP x SNP interaction)	3/77	0.13182426852104007	1.0	0	0	2.3829381627546766	4.828513147729582	BTG3;COMMD10;VRK2
GWAS_Catalog_2019	Bronchopulmonary dysplasia	2/39	0.13329976212656064	1.0	0	0	3.136516897984788	6.320567196098128	TRPS1;MAGI2
GWAS_Catalog_2019	Fasting blood glucose	2/39	0.13329976212656064	1.0	0	0	3.136516897984788	6.320567196098128	VPS13C;SPC25
GWAS_Catalog_2019	Metabolite levels (small molecules and protein measures)	2/39	0.13329976212656064	1.0	0	0	3.136516897984788	6.320567196098128	LMAN2;PRKAG2
GWAS_Catalog_2019	Optic nerve measurement (cup area)	1/9	0.13791011186746688	1.0	0	0	6.7957866123003745	13.463494185072255	SCFD2
GWAS_Catalog_2019	Paneth cell defects in Crohn's disease	1/9	0.13791011186746688	1.0	0	0	6.7957866123003745	13.463494185072255	FER
GWAS_Catalog_2019	Cardiovascular risk factors (age interaction)	1/9	0.13791011186746688	1.0	0	0	6.7957866123003745	13.463494185072255	STX16
GWAS_Catalog_2019	Cerebrospinal fluid beta-site APP cleaving enzyme levels	1/9	0.13791011186746688	1.0	0	0	6.7957866123003745	13.463494185072255	RGS20
GWAS_Catalog_2019	Cerebrospinal fluid p-Tau181p:AB1-42 ratio	1/9	0.13791011186746688	1.0	0	0	6.7957866123003745	13.463494185072255	TTC28
GWAS_Catalog_2019	Response to radiotherapy in cancer (late toxicity)	1/9	0.13791011186746688	1.0	0	0	6.7957866123003745	13.463494185072255	RBMS3
GWAS_Catalog_2019	Social autistic-like traits	1/9	0.13791011186746688	1.0	0	0	6.7957866123003745	13.463494185072255	RIC8B
GWAS_Catalog_2019	Social science traits (pleiotropy) (HIPO component 1)	1/9	0.13791011186746688	1.0	0	0	6.7957866123003745	13.463494185072255	SDK1
GWAS_Catalog_2019	Disc degeneration (lumbar)	1/9	0.13791011186746688	1.0	0	0	6.7957866123003745	13.463494185072255	GPC6
GWAS_Catalog_2019	Forehead morphology	1/9	0.13791011186746688	1.0	0	0	6.7957866123003745	13.463494185072255	ERC1
GWAS_Catalog_2019	IgG digalactosylation phenotypes (multivariate analysis)	1/9	0.13791011186746688	1.0	0	0	6.7957866123003745	13.463494185072255	FUT8
GWAS_Catalog_2019	IgG monogalactosylation phenotypes (multivariate analysis)	1/9	0.13791011186746688	1.0	0	0	6.7957866123003745	13.463494185072255	FUT8
GWAS_Catalog_2019	Post bronchodilator FEV1 in COPD	2/40	0.1388733064589327	1.0	0	0	3.058103975535168	6.0372881523298325	IREB2;RBMS3
GWAS_Catalog_2019	Erosive tooth wear (severe vs non-severe)	2/40	0.1388733064589327	1.0	0	0	3.058103975535168	6.0372881523298325	FUT8;SKAP2
GWAS_Catalog_2019	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)	3/79	0.13928786253616895	1.0	0	0	2.3226106143305074	4.578359154156182	FER;LCORL;EZH2
GWAS_Catalog_2019	Chronic kidney disease	3/81	0.1468907550355565	1.0	0	0	2.2652622041001247	4.344922712672684	UBE2Q2;LMAN2;PRKAG2
GWAS_Catalog_2019	Waist circumference adjusted for BMI (adjusted for smoking behaviour)	3/81	0.1468907550355565	1.0	0	0	2.2652622041001247	4.344922712672684	FER;LCORL;EZH2
GWAS_Catalog_2019	Reticulocyte count	5/171	0.14930827049873574	1.0	0	0	1.7883648979737825	3.4010089611428023	EIF2AK1;MAST2;TRPS1;VPS13A;ATR
GWAS_Catalog_2019	Systemic juvenile idiopathic arthritis	2/42	0.15016678908519976	1.0	0	0	2.91247997670016	5.5220873027069475	PRICKLE2;HDAC9
GWAS_Catalog_2019	Cognitive decline rate in late mild cognitive impairment	4/126	0.15186820258015238	1.0	0	0	1.9416533178001067	3.659515989637062	SDK1;GNG2;MAGI3;CADPS
GWAS_Catalog_2019	Heel bone mineral density	19/898	0.1519263198477063	1.0	0	0	1.294075178956975	2.4385030040635374	FHOD3;RERE;UBE2E3;MEOX2;SUPT3H;ARHGAP24;STK3;RPS6KA5;NAV3;PRKD3;TRPS1;SMARCAD1;TRMT11;LCORL;MAP4K5;GPC6;LGR4;ADAMTS6;RBMS3
GWAS_Catalog_2019	Acylcarnitine levels	1/10	0.15201160650243434	1.0	0	0	6.116207951070336	11.521702767476336	ACADM
GWAS_Catalog_2019	N-glycan levels	1/10	0.15201160650243434	1.0	0	0	6.116207951070336	11.521702767476336	FUT8
GWAS_Catalog_2019	Anthropometric traits	1/10	0.15201160650243434	1.0	0	0	6.116207951070336	11.521702767476336	SGCD
GWAS_Catalog_2019	Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid)	1/10	0.15201160650243434	1.0	0	0	6.116207951070336	11.521702767476336	FEN1
GWAS_Catalog_2019	CSF tryptophan concentration in tuberculous meningitis	1/10	0.15201160650243434	1.0	0	0	6.116207951070336	11.521702767476336	BMPER
GWAS_Catalog_2019	Seborrheic dermatitis	1/10	0.15201160650243434	1.0	0	0	6.116207951070336	11.521702767476336	PRICKLE2
GWAS_Catalog_2019	Deep ovarian and/or rectovaginal disease with dense adhesions	1/10	0.15201160650243434	1.0	0	0	6.116207951070336	11.521702767476336	NAALADL2
GWAS_Catalog_2019	Sporadic neuroblastoma	1/10	0.15201160650243434	1.0	0	0	6.116207951070336	11.521702767476336	BARD1
GWAS_Catalog_2019	Familial lung cancer	1/10	0.15201160650243434	1.0	0	0	6.116207951070336	11.521702767476336	GPATCH2
GWAS_Catalog_2019	Folate pathway vitamin levels	1/10	0.15201160650243434	1.0	0	0	6.116207951070336	11.521702767476336	PRICKLE2
GWAS_Catalog_2019	Uterine fibroid size (maximum dimension)	1/10	0.15201160650243434	1.0	0	0	6.116207951070336	11.521702767476336	EDIL3
GWAS_Catalog_2019	Hip minimal joint space width	1/10	0.15201160650243434	1.0	0	0	6.116207951070336	11.521702767476336	SUPT3H
GWAS_Catalog_2019	IgG fucosylation phenotypes (multivariate analysis)	1/10	0.15201160650243434	1.0	0	0	6.116207951070336	11.521702767476336	FUT8
GWAS_Catalog_2019	IgG sialylation phenotypes (multivariate analysis)	1/10	0.15201160650243434	1.0	0	0	6.116207951070336	11.521702767476336	FUT8
GWAS_Catalog_2019	Laryngeal squamous cell carcinoma	1/10	0.15201160650243434	1.0	0	0	6.116207951070336	11.521702767476336	FEN1
GWAS_Catalog_2019	Logical memory (immediate recall) in Alzheimer's disease dementia	1/10	0.15201160650243434	1.0	0	0	6.116207951070336	11.521702767476336	PSMF1
GWAS_Catalog_2019	Longevity (90 years and older)	1/10	0.15201160650243434	1.0	0	0	6.116207951070336	11.521702767476336	RGS7
GWAS_Catalog_2019	Midgestational circulating levels of PBDEs (fetal genetic effect)	1/10	0.15201160650243434	1.0	0	0	6.116207951070336	11.521702767476336	TBC1D5
GWAS_Catalog_2019	Cognitive decline (age-related)	2/43	0.1558806046259187	1.0	0	0	2.844747884218761	5.2874330978687	TRPS1;G2E3
GWAS_Catalog_2019	Cerebrospinal T-tau levels	2/44	0.16163519854697006	1.0	0	0	2.780094523213789	5.06648135619196	MTBP;TTC28
GWAS_Catalog_2019	Age-related macular degeneration (extreme sampling)	1/11	0.16588313247512798	1.0	0	0	5.5601890464275785	9.988722601051368	KCNT2
GWAS_Catalog_2019	Oropharynx cancer	1/11	0.16588313247512798	1.0	0	0	5.5601890464275785	9.988722601051368	WDFY3
GWAS_Catalog_2019	Bipolar disorder or attention deficit hyperactivity disorder	1/11	0.16588313247512798	1.0	0	0	5.5601890464275785	9.988722601051368	NLGN1
GWAS_Catalog_2019	Peripheral artery disease	1/11	0.16588313247512798	1.0	0	0	5.5601890464275785	9.988722601051368	HDAC9
GWAS_Catalog_2019	Proinsulin levels	1/11	0.16588313247512798	1.0	0	0	5.5601890464275785	9.988722601051368	VPS13C
GWAS_Catalog_2019	Cannabis use	1/11	0.16588313247512798	1.0	0	0	5.5601890464275785	9.988722601051368	SDK1
GWAS_Catalog_2019	Response to alcohol consumption (flushing response)	1/11	0.16588313247512798	1.0	0	0	5.5601890464275785	9.988722601051368	NAALADL2
GWAS_Catalog_2019	Conotruncal heart defects	1/11	0.16588313247512798	1.0	0	0	5.5601890464275785	9.988722601051368	SMCHD1
GWAS_Catalog_2019	Retinopathy in non-diabetics	1/11	0.16588313247512798	1.0	0	0	5.5601890464275785	9.988722601051368	HDAC9
GWAS_Catalog_2019	Sitting height ratio	1/11	0.16588313247512798	1.0	0	0	5.5601890464275785	9.988722601051368	MYO18A
GWAS_Catalog_2019	Tonometry	1/11	0.16588313247512798	1.0	0	0	5.5601890464275785	9.988722601051368	GPC6
GWAS_Catalog_2019	F-cell distribution	1/11	0.16588313247512798	1.0	0	0	5.5601890464275785	9.988722601051368	PRDM5
GWAS_Catalog_2019	Glucocorticoid-induced osteonecrosis (age 10 years and older)	1/11	0.16588313247512798	1.0	0	0	5.5601890464275785	9.988722601051368	CWC27
GWAS_Catalog_2019	Hair shape	1/11	0.16588313247512798	1.0	0	0	5.5601890464275785	9.988722601051368	FRAS1
GWAS_Catalog_2019	Kidney function decline traits	1/11	0.16588313247512798	1.0	0	0	5.5601890464275785	9.988722601051368	MEOX2
GWAS_Catalog_2019	Mortality in heart failure	1/11	0.16588313247512798	1.0	0	0	5.5601890464275785	9.988722601051368	ADAMTS12
GWAS_Catalog_2019	Endometrial cancer	2/45	0.1674277225648568	1.0	0	0	2.7183146449201496	4.858181523393725	NAV3;RUVBL1
GWAS_Catalog_2019	Metabolic syndrome	2/45	0.1674277225648568	1.0	0	0	2.7183146449201496	4.858181523393725	ERCC4;DYRK1A
GWAS_Catalog_2019	Body mass index	25/1246	0.16939425269097538	1.0	0	0	1.2271685295084944	2.1788701518054063	URI1;USP37;MAST2;ZCCHC17;STK33;ADAM23;ERC1;NTNG1;TANGO6;FANCL;ASCC1;VPS13C;UBE2E3;MAGI2;FBXL17;PUM2;TTLL7;SPOCD1;STAG1;PRKD3;KIF16B;VEPH1;NDUFS1;C3ORF67;CCDC171
GWAS_Catalog_2019	Reticulocyte fraction of red cells	5/180	0.17300234698184572	1.0	0	0	1.6989466530750934	2.980717156315545	HERC1;EIF2AK1;TRPS1;VPS13A;ATR
GWAS_Catalog_2019	Cadmium levels	2/46	0.17325541013376514	1.0	0	0	2.6592208482914503	4.661583337525242	IMMP2L;IRAK1BP1
GWAS_Catalog_2019	Erectile dysfunction	2/46	0.17325541013376514	1.0	0	0	2.6592208482914503	4.661583337525242	KIAA1841;CCNC
GWAS_Catalog_2019	Late-onset Alzheimer's disease	2/46	0.17325541013376514	1.0	0	0	2.6592208482914503	4.661583337525242	IRAK1BP1;HDAC9
GWAS_Catalog_2019	Plateletcrit	6/231	0.1784867517216861	1.0	0	0	1.5886254418364512	2.7375843370482764	NAV3;TBC1D5;DIP2B;MSI2;ZFPM2;HDAC9
GWAS_Catalog_2019	Paclitaxel disposition in epithelial ovarian cancer	2/47	0.17911557447813906	1.0	0	0	2.6026416813065256	4.475825399230423	ABLIM1;VRK2
GWAS_Catalog_2019	Autism spectrum disorder, ADHD, bipolar disorder, MDD, and schizophrenia (combined)	2/47	0.17911557447813906	1.0	0	0	2.6026416813065256	4.475825399230423	RERE;ZFPM2
GWAS_Catalog_2019	Pelvic organ prolapse (moderate/severe)	2/47	0.17911557447813906	1.0	0	0	2.6026416813065256	4.475825399230423	LYPLA1;STAU2
GWAS_Catalog_2019	Diabetic retinopathy	2/47	0.17911557447813906	1.0	0	0	2.6026416813065256	4.475825399230423	ARHGAP22;VEPH1
GWAS_Catalog_2019	Telomere length	2/47	0.17911557447813906	1.0	0	0	2.6026416813065256	4.475825399230423	GINS1;TTC37
GWAS_Catalog_2019	Ossification of the posterior longitudinal ligament of the spine	1/12	0.17952842868820532	1.0	0	0	5.096839959225281	8.7534235805355	SUPT3H
GWAS_Catalog_2019	PR segment	1/12	0.17952842868820532	1.0	0	0	5.096839959225281	8.7534235805355	ARHGAP24
GWAS_Catalog_2019	Bipolar disorder (body mass index interaction)	1/12	0.17952842868820532	1.0	0	0	5.096839959225281	8.7534235805355	FBXL17
GWAS_Catalog_2019	Peripheral arterial disease (traffic-related air pollution interaction)	1/12	0.17952842868820532	1.0	0	0	5.096839959225281	8.7534235805355	UTRN
GWAS_Catalog_2019	Prevalent atrial fibrillation	1/12	0.17952842868820532	1.0	0	0	5.096839959225281	8.7534235805355	GMCL1
GWAS_Catalog_2019	Cannabis dependence symptom count	1/12	0.17952842868820532	1.0	0	0	5.096839959225281	8.7534235805355	SCN9A
GWAS_Catalog_2019	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 (Grade 2 peripheral neuropathy)	1/12	0.17952842868820532	1.0	0	0	5.096839959225281	8.7534235805355	GPC6
GWAS_Catalog_2019	Response to anti-retroviral therapy (ddI/d4T) in HIV-1 (Grade 3 peripheral neuropathy)	1/12	0.17952842868820532	1.0	0	0	5.096839959225281	8.7534235805355	HDAC9
GWAS_Catalog_2019	Chronic bronchitis and chronic obstructive pulmonary disease	1/12	0.17952842868820532	1.0	0	0	5.096839959225281	8.7534235805355	IREB2
GWAS_Catalog_2019	Chronic venous disease	1/12	0.17952842868820532	1.0	0	0	5.096839959225281	8.7534235805355	SKAP2
GWAS_Catalog_2019	Cleft lip with or without cleft palate (maternal periconceptional vitamin use interaction)	1/12	0.17952842868820532	1.0	0	0	5.096839959225281	8.7534235805355	TTC28
GWAS_Catalog_2019	Dimensional psychopathology (Cognitive)	1/12	0.17952842868820532	1.0	0	0	5.096839959225281	8.7534235805355	SDK1
GWAS_Catalog_2019	Energy expenditure (24h)	1/12	0.17952842868820532	1.0	0	0	5.096839959225281	8.7534235805355	GPATCH2
GWAS_Catalog_2019	Eye color	1/12	0.17952842868820532	1.0	0	0	5.096839959225281	8.7534235805355	FBXL17
GWAS_Catalog_2019	Freckles	1/12	0.17952842868820532	1.0	0	0	5.096839959225281	8.7534235805355	MSI2
GWAS_Catalog_2019	Frontotemporal dementia with GRN mutation	1/12	0.17952842868820532	1.0	0	0	5.096839959225281	8.7534235805355	NDUFS1
GWAS_Catalog_2019	IgG N-glycosylation phenotypes (multivariate analysis)	1/12	0.17952842868820532	1.0	0	0	5.096839959225281	8.7534235805355	FUT8
GWAS_Catalog_2019	Ischemic stroke (cardioembolic)	1/12	0.17952842868820532	1.0	0	0	5.096839959225281	8.7534235805355	RGS7
GWAS_Catalog_2019	Attention deficit hyperactivity disorder	3/90	0.18263118551220092	1.0	0	0	2.038735983690112	3.4664353505931764	ZNF544;GPC6;SUPT3H
GWAS_Catalog_2019	Alzheimer's disease	2/48	0.18500560680400413	1.0	0	0	2.5484199796126403	4.300125247997936	TTLL7;BMPER
GWAS_Catalog_2019	Response to anti-depressant treatment in major depressive disorder	1/13	0.19295117345871013	1.0	0	0	4.704775346977182	7.740852078779093	MAGI2
GWAS_Catalog_2019	Tenofovir clearance in HIV infection	1/13	0.19295117345871013	1.0	0	0	4.704775346977182	7.740852078779093	TTLL7
GWAS_Catalog_2019	Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	1/13	0.19295117345871013	1.0	0	0	4.704775346977182	7.740852078779093	BMPER
GWAS_Catalog_2019	Eye morphology	1/13	0.19295117345871013	1.0	0	0	4.704775346977182	7.740852078779093	SAMD12
GWAS_Catalog_2019	Urinary metabolite concentrations in chronic kidney disease	1/13	0.19295117345871013	1.0	0	0	4.704775346977182	7.740852078779093	C3ORF67
GWAS_Catalog_2019	Hearing function	1/13	0.19295117345871013	1.0	0	0	4.704775346977182	7.740852078779093	ARFGEF1
GWAS_Catalog_2019	IgG galactosylation phenotypes (multivariate analysis)	1/13	0.19295117345871013	1.0	0	0	4.704775346977182	7.740852078779093	FUT8
GWAS_Catalog_2019	Lymphoma	1/13	0.19295117345871013	1.0	0	0	4.704775346977182	7.740852078779093	TAP2
GWAS_Catalog_2019	Metabolite levels (MHPG)	1/13	0.19295117345871013	1.0	0	0	4.704775346977182	7.740852078779093	NAALADL2
GWAS_Catalog_2019	Blood metabolite ratios	2/50	0.1968652191827804	1.0	0	0	2.4464831804281344	3.976112418294267	ACADM;SGPP1
GWAS_Catalog_2019	Uterine fibroids	2/50	0.1968652191827804	1.0	0	0	2.4464831804281344	3.976112418294267	SCFD2;SLAIN2
GWAS_Catalog_2019	Rosacea symptom severity	4/141	0.20004843027801292	1.0	0	0	1.7350944542043507	2.792106691579068	KCNQ5;TTC27;PRKG1;STK3
GWAS_Catalog_2019	Sjogren's syndrome	2/51	0.20282995525190836	1.0	0	0	2.3985129219883667	3.826557078203919	IRAK1BP1;MIS18BP1
GWAS_Catalog_2019	Initial pursuit acceleration	2/51	0.20282995525190836	1.0	0	0	2.3985129219883667	3.826557078203919	PLCB4;FANCL
GWAS_Catalog_2019	Type 2 diabetes	9/397	0.20403887053575992	1.0	0	0	1.3865458831141821	2.2038380904213963	SDK1;GALNT14;ATXN7;CALCOCO2;FAF1;SACS;PTEN;TNIK;SLC9B2
GWAS_Catalog_2019	Airway wall thickness	1/14	0.2061549855116307	1.0	0	0	4.36871996505024	6.898763810478469	MAGI2
GWAS_Catalog_2019	Periodontitis	1/14	0.2061549855116307	1.0	0	0	4.36871996505024	6.898763810478469	KCNQ5
GWAS_Catalog_2019	Periodontitis (DPAL)	1/14	0.2061549855116307	1.0	0	0	4.36871996505024	6.898763810478469	NLGN1
GWAS_Catalog_2019	Plasma PCSK9 levels in stable coronary artery disease	1/14	0.2061549855116307	1.0	0	0	4.36871996505024	6.898763810478469	KCNQ5
GWAS_Catalog_2019	Cutaneous squamous cell carcinoma	1/14	0.2061549855116307	1.0	0	0	4.36871996505024	6.898763810478469	TRPS1
GWAS_Catalog_2019	Subcortical brain region volumes	1/14	0.2061549855116307	1.0	0	0	4.36871996505024	6.898763810478469	KTN1
GWAS_Catalog_2019	Early-onset Parkinson's disease	1/14	0.2061549855116307	1.0	0	0	4.36871996505024	6.898763810478469	FER
GWAS_Catalog_2019	Excessive daytime sleepiness	1/14	0.2061549855116307	1.0	0	0	4.36871996505024	6.898763810478469	PATJ
GWAS_Catalog_2019	Upper eyelid morphology	1/14	0.2061549855116307	1.0	0	0	4.36871996505024	6.898763810478469	RERE
GWAS_Catalog_2019	Heart rate variability traits (SDNN)	1/14	0.2061549855116307	1.0	0	0	4.36871996505024	6.898763810478469	OPCML
GWAS_Catalog_2019	Mammographic density (dense area)	1/14	0.2061549855116307	1.0	0	0	4.36871996505024	6.898763810478469	MAGI2
GWAS_Catalog_2019	Moderate to vigorous physical activity levels	1/14	0.2061549855116307	1.0	0	0	4.36871996505024	6.898763810478469	C11ORF80
GWAS_Catalog_2019	Protein quantitative trait loci	2/52	0.2088148678697616	1.0	0	0	2.352387673488591	3.684561795426712	SACS;DOCK2
GWAS_Catalog_2019	Neurociticism	3/97	0.2118548994246438	1.0	0	0	1.891610706516599	2.935503027182532	BARD1;FBXL17;VRK2
GWAS_Catalog_2019	Red blood cell count	6/246	0.21608090696085624	1.0	0	0	1.4917580368464236	2.2855260269535362	LMAN2;UBE2E3;MAST2;TRPS1;PRKAG2;ATR
GWAS_Catalog_2019	Moyamoya disease	1/15	0.21914342491142413	1.0	0	0	4.077471967380224	6.18972010296893	HDAC9
GWAS_Catalog_2019	PR interval in Tripanosoma cruzi seropositivity	1/15	0.21914342491142413	1.0	0	0	4.077471967380224	6.18972010296893	YES1
GWAS_Catalog_2019	Personality dimensions	1/15	0.21914342491142413	1.0	0	0	4.077471967380224	6.18972010296893	CLOCK
GWAS_Catalog_2019	Blood trace element (Cu levels)	1/15	0.21914342491142413	1.0	0	0	4.077471967380224	6.18972010296893	EDIL3
GWAS_Catalog_2019	Post-traumatic stress disorder (asjusted for relatedness)	1/15	0.21914342491142413	1.0	0	0	4.077471967380224	6.18972010296893	TRPS1
GWAS_Catalog_2019	Prostate cancer (advanced)	1/15	0.21914342491142413	1.0	0	0	4.077471967380224	6.18972010296893	LARP4B
GWAS_Catalog_2019	Prostate cancer (early onset)	1/15	0.21914342491142413	1.0	0	0	4.077471967380224	6.18972010296893	LARP4B
GWAS_Catalog_2019	Response to taxane treatment (docetaxel)	1/15	0.21914342491142413	1.0	0	0	4.077471967380224	6.18972010296893	TTLL7
GWAS_Catalog_2019	Sense of smell	1/15	0.21914342491142413	1.0	0	0	4.077471967380224	6.18972010296893	DHX15
GWAS_Catalog_2019	Subjective response to lithium treatment in bipolar disorder	1/15	0.21914342491142413	1.0	0	0	4.077471967380224	6.18972010296893	USO1
GWAS_Catalog_2019	Exploratory eye movement dysfunction in schizophrenia (cognitive search score)	1/15	0.21914342491142413	1.0	0	0	4.077471967380224	6.18972010296893	TAF8
GWAS_Catalog_2019	Uterine fibroid number (single vs multiple)	1/15	0.21914342491142413	1.0	0	0	4.077471967380224	6.18972010296893	BMPER
GWAS_Catalog_2019	Glycerophospholipid levels	1/15	0.21914342491142413	1.0	0	0	4.077471967380224	6.18972010296893	SGPP1
GWAS_Catalog_2019	Infant length	1/15	0.21914342491142413	1.0	0	0	4.077471967380224	6.18972010296893	LCORL
GWAS_Catalog_2019	Pursuit maintenance gain	3/99	0.2203863712943294	1.0	0	0	1.8533963488091931	2.803026670091635	VEZT;YES1;MAGI2
GWAS_Catalog_2019	Neutrophil percentage of granulocytes	4/148	0.2239410086804984	1.0	0	0	1.6530291759649558	2.4735475922238157	RERE;APBB1IP;PTEN;LARP4B
GWAS_Catalog_2019	Alcohol dependence	2/55	0.2268685464298277	1.0	0	0	2.2240756185710318	3.299159343577348	ZCCHC17;OPCML
GWAS_Catalog_2019	Obesity	2/55	0.2268685464298277	1.0	0	0	2.2240756185710318	3.299159343577348	FANCL;UBE2E3
GWAS_Catalog_2019	Serum uric acid levels	2/55	0.2268685464298277	1.0	0	0	2.2240756185710318	3.299159343577348	NDUFAF6;RGS20
GWAS_Catalog_2019	Bone mineral density (paediatric, skull)	1/16	0.2319199940423297	1.0	0	0	3.82262996941896	5.586249312145293	LGR4
GWAS_Catalog_2019	Stearic acid (18:0) levels	1/16	0.2319199940423297	1.0	0	0	3.82262996941896	5.586249312145293	FEN1
GWAS_Catalog_2019	Electroencephalogram traits	1/16	0.2319199940423297	1.0	0	0	3.82262996941896	5.586249312145293	MSH2
GWAS_Catalog_2019	Vascular endothelial growth factor levels	1/16	0.2319199940423297	1.0	0	0	3.82262996941896	5.586249312145293	ZFPM2
GWAS_Catalog_2019	Glioblastoma	1/16	0.2319199940423297	1.0	0	0	3.82262996941896	5.586249312145293	SSBP2
GWAS_Catalog_2019	Loneliness	3/104	0.2420001829722992	1.0	0	0	1.7642907551164433	2.503205357695581	EDIL3;HDAC9;NAALADL2
GWAS_Catalog_2019	Plasma omega-6 polyunsaturated fatty acid levels (adrenic acid)	1/17	0.24448813849408715	1.0	0	0	3.5977693829825514	5.067776522974048	FEN1
GWAS_Catalog_2019	Red blood cell fatty acid levels	1/17	0.24448813849408715	1.0	0	0	3.5977693829825514	5.067776522974048	FEN1
GWAS_Catalog_2019	Cough in response to angiotensin-converting enzyme inhibitor drugs	1/17	0.24448813849408715	1.0	0	0	3.5977693829825514	5.067776522974048	SLC38A6
GWAS_Catalog_2019	Serum folate levels	1/17	0.24448813849408715	1.0	0	0	3.5977693829825514	5.067776522974048	MAGI2
GWAS_Catalog_2019	Sphingolipid levels	1/17	0.24448813849408715	1.0	0	0	3.5977693829825514	5.067776522974048	SGPP1
GWAS_Catalog_2019	Fat distribution (HIV)	1/17	0.24448813849408715	1.0	0	0	3.5977693829825514	5.067776522974048	KATNAL1
GWAS_Catalog_2019	Cognitive ability	2/58	0.24502694629870025	1.0	0	0	2.1090372245070124	2.9661227240169787	GPD2;MED27
GWAS_Catalog_2019	Craniofacial microsomia	2/58	0.24502694629870025	1.0	0	0	2.1090372245070124	2.9661227240169787	GNG2;AGAP1
GWAS_Catalog_2019	Aggressiveness in attention deficit hyperactivity disorder	1/18	0.2568512480614548	1.0	0	0	3.3978933061501873	4.618614213300575	PHLPP1
GWAS_Catalog_2019	Oleic acid (18:1n-9) levels	1/18	0.2568512480614548	1.0	0	0	3.3978933061501873	4.618614213300575	FEN1
GWAS_Catalog_2019	Peanut allergy	1/18	0.2568512480614548	1.0	0	0	3.3978933061501873	4.618614213300575	ARHGAP24
GWAS_Catalog_2019	Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid)	1/18	0.2568512480614548	1.0	0	0	3.3978933061501873	4.618614213300575	FEN1
GWAS_Catalog_2019	Preeclampsia	1/18	0.2568512480614548	1.0	0	0	3.3978933061501873	4.618614213300575	INVS
GWAS_Catalog_2019	Renal cell carcinoma	1/18	0.2568512480614548	1.0	0	0	3.3978933061501873	4.618614213300575	FAF1
GWAS_Catalog_2019	Familial lung adenocarcinoma	1/18	0.2568512480614548	1.0	0	0	3.3978933061501873	4.618614213300575	NAALADL2
GWAS_Catalog_2019	Interferon alpha levels in systemic lupus erythematosus	1/18	0.2568512480614548	1.0	0	0	3.3978933061501873	4.618614213300575	PRKG1
GWAS_Catalog_2019	Lead levels in blood	1/18	0.2568512480614548	1.0	0	0	3.3978933061501873	4.618614213300575	MAGI2
GWAS_Catalog_2019	Cerebrospinal fluid AB1-42 levels	2/60	0.25716486438471875	1.0	0	0	2.038735983690112	2.7686807422974944	NLN;TNIK
GWAS_Catalog_2019	Subcutaneous adipose tissue	2/61	0.2632381031318644	1.0	0	0	2.0053140823181432	2.676485328662697	RNGTT;CDC73
GWAS_Catalog_2019	Blond vs. brown/black hair color	4/160	0.2664290812322477	1.0	0	0	1.529051987767584	2.022396303500186	FRAS1;ADAMTS12;ARHGAP24;LGR4
GWAS_Catalog_2019	Menarche (age at onset)	5/212	0.2667956237224148	1.0	0	0	1.4425018752524381	1.9059378684362147	FUT8;AGAP1;SMARCAD1;TRMT11;LGR4
GWAS_Catalog_2019	Alcohol dependence symptom count	1/19	0.2690126574689621	1.0	0	0	3.2190568163528086	4.226611449217221	NDUFAF6
GWAS_Catalog_2019	Blood trace element (Zn levels)	1/19	0.2690126574689621	1.0	0	0	3.2190568163528086	4.226611449217221	MEOX2
GWAS_Catalog_2019	Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test)	1/19	0.2690126574689621	1.0	0	0	3.2190568163528086	4.226611449217221	POC1B
GWAS_Catalog_2019	Subjective response to lithium treatment	1/19	0.2690126574689621	1.0	0	0	3.2190568163528086	4.226611449217221	FGGY
GWAS_Catalog_2019	Feeling tense	1/19	0.2690126574689621	1.0	0	0	3.2190568163528086	4.226611449217221	ADAMTS6
GWAS_Catalog_2019	Initial pursuit acceleration in psychotic disorders	1/19	0.2690126574689621	1.0	0	0	3.2190568163528086	4.226611449217221	PLCB4
GWAS_Catalog_2019	Corneal astigmatism	2/63	0.2753846795625301	1.0	0	0	1.9416533178001067	2.5039295645855275	BMPER;PARD3
GWAS_Catalog_2019	Nephropathy	1/20	0.2809756474487896	1.0	0	0	3.058103975535168	3.8822240895634055	TAP2
GWAS_Catalog_2019	Blood osmolality (transformed sodium)	1/20	0.2809756474487896	1.0	0	0	3.058103975535168	3.8822240895634055	KATNAL1
GWAS_Catalog_2019	Primary tooth development (number of teeth)	1/20	0.2809756474487896	1.0	0	0	3.058103975535168	3.8822240895634055	ADK
GWAS_Catalog_2019	Primary tooth development (time to first tooth eruption)	1/20	0.2809756474487896	1.0	0	0	3.058103975535168	3.8822240895634055	ADK
GWAS_Catalog_2019	C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	1/20	0.2809756474487896	1.0	0	0	3.058103975535168	3.8822240895634055	STAG1
GWAS_Catalog_2019	Response to angiotensin II receptor blocker therapy	1/20	0.2809756474487896	1.0	0	0	3.058103975535168	3.8822240895634055	APBB1IP
GWAS_Catalog_2019	Response to hepatitis B vaccine	1/20	0.2809756474487896	1.0	0	0	3.058103975535168	3.8822240895634055	TAP2
GWAS_Catalog_2019	Eating disorders	1/20	0.2809756474487896	1.0	0	0	3.058103975535168	3.8822240895634055	TRPS1
GWAS_Catalog_2019	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	1/20	0.2809756474487896	1.0	0	0	3.058103975535168	3.8822240895634055	NLGN1
GWAS_Catalog_2019	Type 2 diabetes (SNP x SNP interaction, 2df)	1/20	0.2809756474487896	1.0	0	0	3.058103975535168	3.8822240895634055	NAALADL2
GWAS_Catalog_2019	Venous thromboembolism	1/20	0.2809756474487896	1.0	0	0	3.058103975535168	3.8822240895634055	ZFPM2
GWAS_Catalog_2019	Alzheimer's disease in APOE e4+ carriers	1/21	0.2927434455404015	1.0	0	0	2.91247997670016	3.5778612670094865	IMMP2L
GWAS_Catalog_2019	Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid)	1/21	0.2927434455404015	1.0	0	0	2.91247997670016	3.5778612670094865	FEN1
GWAS_Catalog_2019	Plasma parathyroid hormone levels	1/21	0.2927434455404015	1.0	0	0	2.91247997670016	3.5778612670094865	ORC2
GWAS_Catalog_2019	Colorectal cancer (diet interaction)	1/21	0.2927434455404015	1.0	0	0	2.91247997670016	3.5778612670094865	LCORL
GWAS_Catalog_2019	Gut microbiota (beta diversity)	1/21	0.2927434455404015	1.0	0	0	2.91247997670016	3.5778612670094865	PRKAG2
GWAS_Catalog_2019	Kawasaki disease	1/21	0.2927434455404015	1.0	0	0	2.91247997670016	3.5778612670094865	NAALADL2
GWAS_Catalog_2019	Cognitive performance	3/116	0.2950278762959173	1.0	0	0	1.5817779183802594	1.9308532603423152	IMMP2L;ATL1;MAP4K5
GWAS_Catalog_2019	PR interval	2/67	0.2996342095191176	1.0	0	0	1.825733716737414	2.2003612212001893	ZFPM2;ARHGAP24
GWAS_Catalog_2019	Ischemic stroke	2/67	0.2996342095191176	1.0	0	0	1.825733716737414	2.2003612212001893	FUT8;HDAC9
GWAS_Catalog_2019	Lung function (FEV1)	2/67	0.2996342095191176	1.0	0	0	1.825733716737414	2.2003612212001893	GSTCD;KCNS3
GWAS_Catalog_2019	Asthma and hay fever	1/22	0.304319226935029	1.0	0	0	2.780094523213789	3.3074174032004824	EDIL3
GWAS_Catalog_2019	Response to cognitive-behavioural therapy in anxiety disorder	1/22	0.304319226935029	1.0	0	0	2.780094523213789	3.3074174032004824	NTNG1
GWAS_Catalog_2019	Response to platinum-based neoadjuvant chemotherapy in cervical cancer	1/22	0.304319226935029	1.0	0	0	2.780094523213789	3.3074174032004824	RPS6KA5
GWAS_Catalog_2019	Heart rate response to recovery post exercise (10 sec)	1/22	0.304319226935029	1.0	0	0	2.780094523213789	3.3074174032004824	CLPB
GWAS_Catalog_2019	Mitochondrial DNA levels	1/22	0.304319226935029	1.0	0	0	2.780094523213789	3.3074174032004824	EDIL3
GWAS_Catalog_2019	Mortality in sepsis	1/22	0.304319226935029	1.0	0	0	2.780094523213789	3.3074174032004824	VPS13A
GWAS_Catalog_2019	Monocyte percentage of white cells	4/171	0.30654318696067834	1.0	0	0	1.430691918379026	1.6916453027281253	APBB1IP;TRPS1;EVI5;CSNK1G1
GWAS_Catalog_2019	Mean corpuscular hemoglobin	7/336	0.31158840790554165	1.0	0	0	1.2742099898063202	1.4858208046905272	SPECC1;SENP7;C11ORF80;AGAP1;PIBF1;ATR;MIPOL1
GWAS_Catalog_2019	Waist circumference adjusted for BMI in non-smokers	2/69	0.31171382922796576	1.0	0	0	1.7728138988609672	2.0665154918827224	LCORL;EZH2
GWAS_Catalog_2019	Sum eosinophil basophil counts	4/173	0.3139129162828955	1.0	0	0	1.4141521274151063	1.6384927517172954	RERE;APBB1IP;PTEN;LARP4B
GWAS_Catalog_2019	White blood cell count	5/227	0.31418303939117664	1.0	0	0	1.3471823680771666	1.5597401755554197	RERE;NFYA;UBE2E3;SPC25;TTC28
GWAS_Catalog_2019	Adolescent idiopathic scoliosis	1/23	0.3157061152970666	1.0	0	0	2.6592208482914503	3.0659314266988047	TNIK
GWAS_Catalog_2019	Non-melanoma skin cancer	1/23	0.3157061152970666	1.0	0	0	2.6592208482914503	3.0659314266988047	GNG2
GWAS_Catalog_2019	Osteoarthritis (hip)	1/23	0.3157061152970666	1.0	0	0	2.6592208482914503	3.0659314266988047	HDAC9
GWAS_Catalog_2019	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	1/23	0.3157061152970666	1.0	0	0	2.6592208482914503	3.0659314266988047	FEN1
GWAS_Catalog_2019	Response to fenofibrate (HDL cholesterol levels)	1/23	0.3157061152970666	1.0	0	0	2.6592208482914503	3.0659314266988047	STK33
GWAS_Catalog_2019	Electrocardiographic traits	1/23	0.3157061152970666	1.0	0	0	2.6592208482914503	3.0659314266988047	ARHGAP24
GWAS_Catalog_2019	IgG glycosylation	1/23	0.3157061152970666	1.0	0	0	2.6592208482914503	3.0659314266988047	FUT8
GWAS_Catalog_2019	Lymphocyte counts	4/174	0.3176038796066346	1.0	0	0	1.4060248163380082	1.6126406331296488	RERE;UBE2E3;TNIK;TTC28
GWAS_Catalog_2019	Glucose homeostasis traits	2/70	0.3177376272400925	1.0	0	0	1.747487986020096	2.003546191931642	SETD5;STARD9
GWAS_Catalog_2019	High density lipoprotein cholesterol levels	2/71	0.32374907257509505	1.0	0	0	1.7228754791747427	1.9430357593236052	GNG2;TRPS1
GWAS_Catalog_2019	Nose morphology	1/24	0.3269071836790968	1.0	0	0	2.5484199796126403	2.8493348377563352	SUPT3H
GWAS_Catalog_2019	Obstructive sleep apnea trait (apnea hypopnea index)	1/24	0.3269071836790968	1.0	0	0	2.5484199796126403	2.8493348377563352	C3ORF67
GWAS_Catalog_2019	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	1/24	0.3269071836790968	1.0	0	0	2.5484199796126403	2.8493348377563352	SUPT3H
GWAS_Catalog_2019	Childhood body mass index	1/24	0.3269071836790968	1.0	0	0	2.5484199796126403	2.8493348377563352	ADAM23
GWAS_Catalog_2019	Coronary artery disease or large artery stroke	1/24	0.3269071836790968	1.0	0	0	2.5484199796126403	2.8493348377563352	HDAC9
GWAS_Catalog_2019	Diabetic kidney disease	1/24	0.3269071836790968	1.0	0	0	2.5484199796126403	2.8493348377563352	NAV3
GWAS_Catalog_2019	Hypospadias	1/24	0.3269071836790968	1.0	0	0	2.5484199796126403	2.8493348377563352	ADK
GWAS_Catalog_2019	Liver enzyme levels (alkaline phosphatase)	1/24	0.3269071836790968	1.0	0	0	2.5484199796126403	2.8493348377563352	GINS1
GWAS_Catalog_2019	Low tan response	1/24	0.3269071836790968	1.0	0	0	2.5484199796126403	2.8493348377563352	TRPS1
GWAS_Catalog_2019	Tuberculosis	2/72	0.3297469612139558	1.0	0	0	1.6989466530750934	1.8848618804809976	C2CD2;ZFPM2
GWAS_Catalog_2019	Immature fraction of reticulocytes	3/125	0.3352772533832956	1.0	0	0	1.4678899082568808	1.6041063741763784	SPECC1;APBB1IP;TRPS1
GWAS_Catalog_2019	Alzheimer's disease biomarkers	1/25	0.3379254552109012	1.0	0	0	2.4464831804281344	2.65426288571604	EDIL3
GWAS_Catalog_2019	Antineutrophil cytoplasmic antibody-associated vasculitis	1/25	0.3379254552109012	1.0	0	0	2.4464831804281344	2.65426288571604	KATNAL1
GWAS_Catalog_2019	Response to antipsychotic treatment	1/25	0.3379254552109012	1.0	0	0	2.4464831804281344	2.65426288571604	FHOD3
GWAS_Catalog_2019	Spherical equivalent (joint analysis main effects and education interaction)	1/25	0.3379254552109012	1.0	0	0	2.4464831804281344	2.65426288571604	KCNQ5
GWAS_Catalog_2019	Thyroid stimulating hormone	1/25	0.3379254552109012	1.0	0	0	2.4464831804281344	2.65426288571604	PTEN
GWAS_Catalog_2019	Facial emotion recognition (sad faces)	1/25	0.3379254552109012	1.0	0	0	2.4464831804281344	2.65426288571604	POLR1A
GWAS_Catalog_2019	Feeling hurt	1/25	0.3379254552109012	1.0	0	0	2.4464831804281344	2.65426288571604	BTG3
GWAS_Catalog_2019	Monobrow thickness	1/25	0.3379254552109012	1.0	0	0	2.4464831804281344	2.65426288571604	PRDM5
GWAS_Catalog_2019	Prostate cancer (SNP x SNP interaction)	2/74	0.3416974636200489	1.0	0	0	1.6530291759649558	1.775071564121561	ABLIM1;CEP152
GWAS_Catalog_2019	Chronic lymphocytic leukemia	2/74	0.3416974636200489	1.0	0	0	1.6530291759649558	1.775071564121561	PRKD3;FAM126B
GWAS_Catalog_2019	Small cell lung carcinoma	2/74	0.3416974636200489	1.0	0	0	1.6530291759649558	1.775071564121561	STK33;SKAP2
GWAS_Catalog_2019	Urate levels	2/74	0.3416974636200489	1.0	0	0	1.6530291759649558	1.775071564121561	UBE2Q2;PRKAG2
GWAS_Catalog_2019	Migraine	2/74	0.3416974636200489	1.0	0	0	1.6530291759649558	1.775071564121561	MED14;IMMP2L
GWAS_Catalog_2019	LDL cholesterol	4/181	0.3435199810604008	1.0	0	0	1.351648165982395	1.4442495818143486	COG5;DIP2B;TNIK;EVI5
GWAS_Catalog_2019	Resting heart rate	3/127	0.3442220818344163	1.0	0	0	1.4447735317488983	1.5408050902004615	FHOD3;FEN1;GPATCH2
GWAS_Catalog_2019	Amyotrophic lateral sclerosis (sporadic)	4/182	0.3472292949155448	1.0	0	0	1.3442215277077665	1.4218771045448644	ZFYVE26;EPB41;MGLL;OPCML
GWAS_Catalog_2019	Hypothyroidism	2/75	0.34764787741757663	1.0	0	0	1.6309887869520898	1.7232459253351815	RTKN2;SACS
GWAS_Catalog_2019	Waist circumference adjusted for body mass index	3/128	0.34869099589275554	1.0	0	0	1.43348623853211	1.5102768743759318	FER;LCORL;EZH2
GWAS_Catalog_2019	Hemoglobin concentration	3/128	0.34869099589275554	1.0	0	0	1.43348623853211	1.5102768743759318	NDUFAF6;TRPS1;PRKAG2
GWAS_Catalog_2019	Palmitoleic acid (16:1n-7) levels	1/26	0.34876390415765196	1.0	0	0	2.352387673488591	2.4779112634412703	FEN1
GWAS_Catalog_2019	Perceived unattractiveness to mosquitoes	1/26	0.34876390415765196	1.0	0	0	2.352387673488591	2.4779112634412703	RAPGEF6
GWAS_Catalog_2019	Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)	1/26	0.34876390415765196	1.0	0	0	2.352387673488591	2.4779112634412703	FEN1
GWAS_Catalog_2019	Cancer	1/26	0.34876390415765196	1.0	0	0	2.352387673488591	2.4779112634412703	CNIH3
GWAS_Catalog_2019	Response to fenofibrate (triglyceride levels)	1/26	0.34876390415765196	1.0	0	0	2.352387673488591	2.4779112634412703	UTRN
GWAS_Catalog_2019	Coronary artery aneurysm in Kawasaki disease	1/26	0.34876390415765196	1.0	0	0	2.352387673488591	2.4779112634412703	ZNF618
GWAS_Catalog_2019	Lupus nephritis in systemic lupus erythematosus	1/26	0.34876390415765196	1.0	0	0	2.352387673488591	2.4779112634412703	MAP4K5
GWAS_Catalog_2019	Monobrow	2/76	0.3535803323538061	1.0	0	0	1.6095284081764043	1.6733374713293516	HDAC9;SUPT3H
GWAS_Catalog_2019	Asthma (moderate or severe)	1/27	0.3594254563817229	1.0	0	0	2.2652622041001247	2.3179261001680778	RERE
GWAS_Catalog_2019	Fasting plasma glucose	1/27	0.3594254563817229	1.0	0	0	2.2652622041001247	2.3179261001680778	PRDM5
GWAS_Catalog_2019	White matter hyperintensity burden	1/27	0.3594254563817229	1.0	0	0	2.2652622041001247	2.3179261001680778	CDC73
GWAS_Catalog_2019	Knee osteoarthritis	1/27	0.3594254563817229	1.0	0	0	2.2652622041001247	2.3179261001680778	DDX10
GWAS_Catalog_2019	Neutrophil count	4/187	0.3657795406159486	1.0	0	0	1.3082797756300184	1.3157689906413406	FGGY;PLCB4;MAST2;SPC25
GWAS_Catalog_2019	Bladder cancer	1/28	0.3699129903005613	1.0	0	0	2.18435998252512	2.1723186158769487	CWC27
GWAS_Catalog_2019	Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)	1/28	0.3699129903005613	1.0	0	0	2.18435998252512	2.1723186158769487	FEN1
GWAS_Catalog_2019	Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)	1/28	0.3699129903005613	1.0	0	0	2.18435998252512	2.1723186158769487	TAP2
GWAS_Catalog_2019	Epilepsy and lamotrigine-induced maculopapular eruptions	1/28	0.3699129903005613	1.0	0	0	2.18435998252512	2.1723186158769487	HDAC9
GWAS_Catalog_2019	Urinary albumin excretion (no hypertensive medication)	1/28	0.3699129903005613	1.0	0	0	2.18435998252512	2.1723186158769487	CWC27
GWAS_Catalog_2019	Leprosy	1/28	0.3699129903005613	1.0	0	0	2.18435998252512	2.1723186158769487	BBS9
GWAS_Catalog_2019	Body mass index in physically active individuals	2/80	0.37711107517337983	1.0	0	0	1.529051987767584	1.4911552076783638	STK33;FBXL17
GWAS_Catalog_2019	Obesity (extreme)	1/29	0.3802293377107613	1.0	0	0	2.1090372245070124	2.0393982664037917	RTN4
GWAS_Catalog_2019	Quantitative traits	1/29	0.3802293377107613	1.0	0	0	2.1090372245070124	2.0393982664037917	SDK1
GWAS_Catalog_2019	Sudden cardiac arrest	1/29	0.3802293377107613	1.0	0	0	2.1090372245070124	2.0393982664037917	ZFPM2
GWAS_Catalog_2019	Feeling fed-up	1/29	0.3802293377107613	1.0	0	0	2.1090372245070124	2.0393982664037917	BARD1
GWAS_Catalog_2019	Fractures	1/29	0.3802293377107613	1.0	0	0	2.1090372245070124	2.0393982664037917	RPS6KA5
GWAS_Catalog_2019	Spherical equivalent or myopia (age of diagnosis)	4/191	0.3806041874781136	1.0	0	0	1.2808812462974528	1.2373252917987487	GPD2;KCNQ5;METTL15;GPC6
GWAS_Catalog_2019	Cognitive ability (MTAG)	2/81	0.3829394363996046	1.0	0	0	1.5101748027334163	1.4495842214070724	GPD2;MED27
GWAS_Catalog_2019	Glomerular filtration rate (creatinine)	2/81	0.3829394363996046	1.0	0	0	1.5101748027334163	1.4495842214070724	UBE2Q2;PRKAG2
GWAS_Catalog_2019	Systemic lupus erythematosus	7/365	0.3883921596477829	1.0	0	0	1.172971387876503	1.1093256425554332	PRIM2;FCHSD2;SYT1;RTKN2;EVI5;NAALADL2;SKAP2
GWAS_Catalog_2019	Adiponectin levels	1/30	0.3903772844329572	1.0	0	0	2.038735983690112	1.917719901126268	FER
GWAS_Catalog_2019	Optic cup area	1/30	0.3903772844329572	1.0	0	0	2.038735983690112	1.917719901126268	RERE
GWAS_Catalog_2019	Breast cancer (estrogen-receptor negative)	1/30	0.3903772844329572	1.0	0	0	2.038735983690112	1.917719901126268	FAM126B
GWAS_Catalog_2019	Bulimia nervosa	1/30	0.3903772844329572	1.0	0	0	2.038735983690112	1.917719901126268	MAGI3
GWAS_Catalog_2019	Pubertal anthropometrics	1/30	0.3903772844329572	1.0	0	0	2.038735983690112	1.917719901126268	TAP2
GWAS_Catalog_2019	Refractive error	1/30	0.3903772844329572	1.0	0	0	2.038735983690112	1.917719901126268	KCNQ5
GWAS_Catalog_2019	Toenail selenium levels	1/30	0.3903772844329572	1.0	0	0	2.038735983690112	1.917719901126268	TTLL7
GWAS_Catalog_2019	Microalbuminuria	1/30	0.3903772844329572	1.0	0	0	2.038735983690112	1.917719901126268	PDSS2
GWAS_Catalog_2019	Bone mineral density (total hip)	1/31	0.400359571032317	1.0	0	0	1.972970306796883	1.806041645628472	ERCC4
GWAS_Catalog_2019	Response to amphetamines	1/31	0.400359571032317	1.0	0	0	1.972970306796883	1.806041645628472	FBXL17
GWAS_Catalog_2019	Fasting blood glucose (BMI interaction)	1/31	0.400359571032317	1.0	0	0	1.972970306796883	1.806041645628472	VPS13C
GWAS_Catalog_2019	Uric acid levels	1/31	0.400359571032317	1.0	0	0	1.972970306796883	1.806041645628472	FRAS1
GWAS_Catalog_2019	Myeloid white cell count	3/140	0.40192691600497227	1.0	0	0	1.3106159895150722	1.1946068255223774	MAST2;CSNK1G1;SPC25
GWAS_Catalog_2019	Dialysis-related mortality	1/32	0.4101788936987951	1.0	0	0	1.91131498470948	1.7032910710086229	GPATCH2
GWAS_Catalog_2019	Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)	1/32	0.4101788936987951	1.0	0	0	1.91131498470948	1.7032910710086229	LYPLA1
GWAS_Catalog_2019	Waist-to-hip ratio adjusted for BMI in non-smokers	1/32	0.4101788936987951	1.0	0	0	1.91131498470948	1.7032910710086229	LYPLA1
GWAS_Catalog_2019	Nonsyndromic cleft lip with cleft palate	1/33	0.4198379048403659	1.0	0	0	1.8533963488091931	1.6085378242152433	RAD54B
GWAS_Catalog_2019	Pelvic organ prolapse	1/33	0.4198379048403659	1.0	0	0	1.8533963488091931	1.6085378242152433	GPC6
GWAS_Catalog_2019	Self-reported risk-taking behaviour	1/33	0.4198379048403659	1.0	0	0	1.8533963488091931	1.6085378242152433	TBC1D5
GWAS_Catalog_2019	Urate levels (BMI interaction)	1/33	0.4198379048403659	1.0	0	0	1.8533963488091931	1.6085378242152433	TRPS1
GWAS_Catalog_2019	Hemoglobin	1/33	0.4198379048403659	1.0	0	0	1.8533963488091931	1.6085378242152433	PRKAG2
GWAS_Catalog_2019	Hemoglobin levels	1/34	0.4293392137948646	1.0	0	0	1.7988846914912755	1.5209713336078037	PRKAG2
GWAS_Catalog_2019	Immune reponse to smallpox (secreted IFN-alpha)	1/34	0.4293392137948646	1.0	0	0	1.7988846914912755	1.5209713336078037	MNAT1
GWAS_Catalog_2019	Initial alcohol sensitivity	1/34	0.4293392137948646	1.0	0	0	1.7988846914912755	1.5209713336078037	ARHGAP24
GWAS_Catalog_2019	Testicular germ cell tumor	2/90	0.4342518195377413	1.0	0	0	1.3591573224600748	1.1337148267754815	UCK2;SMARCAD1
GWAS_Catalog_2019	Periodontitis (Mean PAL)	1/35	0.43868538762552656	1.0	0	0	1.747487986020096	1.4398825333643204	PTEN
GWAS_Catalog_2019	Insomnia	1/35	0.43868538762552656	1.0	0	0	1.747487986020096	1.4398825333643204	CEP152
GWAS_Catalog_2019	Mercury levels	1/35	0.43868538762552656	1.0	0	0	1.747487986020096	1.4398825333643204	PTEN
GWAS_Catalog_2019	Body mass index (joint analysis main effects and physical activity interaction)	2/91	0.4398139146915878	1.0	0	0	1.3442215277077665	1.1041483518925796	STK33;FBXL17
GWAS_Catalog_2019	Activated partial thromboplastin time	1/36	0.4478789516442221	1.0	0	0	1.6989466530750934	1.3646487942570793	LMAN2
GWAS_Catalog_2019	Primary sclerosing cholangitis	1/36	0.4478789516442221	1.0	0	0	1.6989466530750934	1.3646487942570793	TANGO6
GWAS_Catalog_2019	Cerebral amyloid deposition in APOEe4 non-carriers (PET imaging)	1/36	0.4478789516442221	1.0	0	0	1.6989466530750934	1.3646487942570793	G2E3
GWAS_Catalog_2019	Gestational age at birth (maternal effect)	1/36	0.4478789516442221	1.0	0	0	1.6989466530750934	1.3646487942570793	RUVBL1
GWAS_Catalog_2019	Hair greying	1/36	0.4478789516442221	1.0	0	0	1.6989466530750934	1.3646487942570793	USP40
GWAS_Catalog_2019	IgA nephropathy	1/36	0.4478789516442221	1.0	0	0	1.6989466530750934	1.3646487942570793	TAP2
GWAS_Catalog_2019	Logical memory (immediate recall) in normal cognition	1/36	0.4478789516442221	1.0	0	0	1.6989466530750934	1.3646487942570793	ZCCHC4
GWAS_Catalog_2019	Lumbar spine bone mineral density	1/36	0.4478789516442221	1.0	0	0	1.6989466530750934	1.3646487942570793	RPS6KA5
GWAS_Catalog_2019	HDL cholesterol levels	2/93	0.4508475827689872	1.0	0	0	1.3153135378645886	1.047812897369761	TRPS1;TAF8
GWAS_Catalog_2019	Eosinophil percentage of granulocytes	3/152	0.453875643336541	1.0	0	0	1.2071463061323031	0.953563534304129	RERE;APBB1IP;PTEN
GWAS_Catalog_2019	Allergy	1/37	0.4569223902625562	1.0	0	0	1.6530291759649558	1.294721426366638	RERE
GWAS_Catalog_2019	Smooth-surface caries	1/37	0.4569223902625562	1.0	0	0	1.6530291759649558	1.294721426366638	BBS9
GWAS_Catalog_2019	Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	1/37	0.4569223902625562	1.0	0	0	1.6530291759649558	1.294721426366638	LNPEP
GWAS_Catalog_2019	Lung cancer in ever smokers	3/153	0.45812436518264293	1.0	0	0	1.1992564609941836	0.9361570930360256	KCNT2;ZSCAN23;RBMS3
GWAS_Catalog_2019	Anti-saccade response	1/38	0.4658181475334312	1.0	0	0	1.6095284081764043	1.2296152621358902	RBMS3
GWAS_Catalog_2019	Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	1/38	0.4658181475334312	1.0	0	0	1.6095284081764043	1.2296152621358902	SGCD
GWAS_Catalog_2019	Corneal structure	1/38	0.4658181475334312	1.0	0	0	1.6095284081764043	1.2296152621358902	ADAMTS6
GWAS_Catalog_2019	Urate levels in lean individuals	1/38	0.4658181475334312	1.0	0	0	1.6095284081764043	1.2296152621358902	TAP2
GWAS_Catalog_2019	Vertical cup-disc ratio	1/38	0.4658181475334312	1.0	0	0	1.6095284081764043	1.2296152621358902	RERE
GWAS_Catalog_2019	Heschl's gyrus morphology	1/38	0.4658181475334312	1.0	0	0	1.6095284081764043	1.2296152621358902	METTL4
GWAS_Catalog_2019	Diastolic blood pressure x alcohol consumption interaction (2df test)	2/96	0.4671645352995538	1.0	0	0	1.2742099898063202	0.9697677871850732	IRAK1BP1;POC1B
GWAS_Catalog_2019	Nose size	1/39	0.4745686278696636	1.0	0	0	1.568258448992394	1.168899928519663	SUPT3H
GWAS_Catalog_2019	Restless legs syndrome	1/39	0.4745686278696636	1.0	0	0	1.568258448992394	1.168899928519663	NTNG1
GWAS_Catalog_2019	Blood pressure	2/98	0.4778817164897909	1.0	0	0	1.2482057043000685	0.9216651465456034	POC1B;MAP4
GWAS_Catalog_2019	Prostate cancer	7/399	0.4786831312915647	1.0	0	0	1.0730189387842697	0.7905106730886449	NAA50;STYX;NOL10;LARP4B;DOCK2;BIRC3;TTC28
GWAS_Catalog_2019	Nickel levels	1/40	0.483176196518698	1.0	0	0	1.529051987767584	1.1121925011414695	SLC38A6
GWAS_Catalog_2019	Carotid plaque burden	1/40	0.483176196518698	1.0	0	0	1.529051987767584	1.1121925011414695	KCNQ5
GWAS_Catalog_2019	Tourette's syndrome or obsessive-compulsive disorder	1/40	0.483176196518698	1.0	0	0	1.529051987767584	1.1121925011414695	WDR7
GWAS_Catalog_2019	Fibrinogen	1/40	0.483176196518698	1.0	0	0	1.529051987767584	1.1121925011414695	DIP2B
GWAS_Catalog_2019	Zinc levels	1/40	0.483176196518698	1.0	0	0	1.529051987767584	1.1121925011414695	HDAC9
GWAS_Catalog_2019	Iron status biomarkers (total iron binding capacity)	1/40	0.483176196518698	1.0	0	0	1.529051987767584	1.1121925011414695	MAST2
GWAS_Catalog_2019	Hip circumference adjusted for BMI	2/99	0.4831908965105165	1.0	0	0	1.2355975658727951	0.898703824226457	FAF1;LCORL
GWAS_Catalog_2019	Eosinophil percentage of white cells	3/160	0.4874559365503355	1.0	0	0	1.1467889908256879	0.8240313981568361	RERE;APBB1IP;PTEN
GWAS_Catalog_2019	Serum metabolite levels	2/100	0.4884666637471902	1.0	0	0	1.2232415902140672	0.876433091010644	FEN1;ACADM
GWAS_Catalog_2019	Cerebral amyloid deposition (PET imaging)	1/41	0.4916431805875322	1.0	0	0	1.4917580368464236	1.0591512915847132	WDFY3
GWAS_Catalog_2019	Childhood ear infection	1/41	0.4916431805875322	1.0	0	0	1.4917580368464236	1.0591512915847132	CDHR3
GWAS_Catalog_2019	Response to statin therapy	2/102	0.4989166633507116	1.0	0	0	1.1992564609941836	0.8338624506698997	RNGTT;GPD2
GWAS_Catalog_2019	Monocyte count	4/224	0.4998889831376736	1.0	0	0	1.09217999126256	0.7572840093247432	TRPS1;POC1B;EVI5;CSNK1G1
GWAS_Catalog_2019	Myopia (pathological)	1/42	0.4999718692246899	1.0	0	0	1.45623998835008	1.0094705747681751	DHX15
GWAS_Catalog_2019	Lung cancer	4/225	0.5033658962913925	1.0	0	0	1.0873258579680598	0.7463817278317066	RIF1;METTL4;ZSCAN23;NAF1
GWAS_Catalog_2019	Mild influenza (H1N1) infection	1/43	0.5081645144112534	1.0	0	0	1.4223739421093806	0.9628760921195016	TTLL7
GWAS_Catalog_2019	Alzheimer's disease in APOE e4- carriers	1/44	0.5162233316645957	1.0	0	0	1.3900472616068946	0.9191212035498402	RAPGEF6
GWAS_Catalog_2019	Angiotensin-converting enzyme inhibitor intolerance	1/44	0.5162233316645957	1.0	0	0	1.3900472616068946	0.9191212035498402	PSMF1
GWAS_Catalog_2019	Low density lipoprotein cholesterol levels	1/44	0.5162233316645957	1.0	0	0	1.3900472616068946	0.9191212035498402	ZNF618
GWAS_Catalog_2019	Femoral neck bone mineral density	1/45	0.5241505004482289	1.0	0	0	1.3591573224600748	0.8779835831511442	RPS6KA5
GWAS_Catalog_2019	Lead levels	1/45	0.5241505004482289	1.0	0	0	1.3591573224600748	0.8779835831511442	TTLL5
GWAS_Catalog_2019	Platelet distribution width	3/170	0.5279731247057738	1.0	0	0	1.0793308148947651	0.6893792733403047	TBC1D5;RTTN;ZFPM2
GWAS_Catalog_2019	Visceral fat	1/46	0.5319481649518849	1.0	0	0	1.3296104241457252	0.8392623702812002	GPC6
GWAS_Catalog_2019	Metabolic traits	1/46	0.5319481649518849	1.0	0	0	1.3296104241457252	0.8392623702812002	ACADM
GWAS_Catalog_2019	Allergic disease (asthma, hay fever or eczema)	3/172	0.5358627531662674	1.0	0	0	1.0667804565820354	0.6655400130416909	RERE;LMAN2;PIBF1
GWAS_Catalog_2019	High light scatter reticulocyte count	3/172	0.5358627531662674	1.0	0	0	1.0667804565820354	0.6655400130416909	SPECC1;EIF2AK1;TRPS1
GWAS_Catalog_2019	High light scatter reticulocyte percentage of red cells	3/172	0.5358627531662674	1.0	0	0	1.0667804565820354	0.6655400130416909	SPECC1;EIF2AK1;TRPS1
GWAS_Catalog_2019	Mean arterial pressure	2/110	0.5393235300912448	1.0	0	0	1.1120378092855157	0.6866162321815504	YES1;MAP4
GWAS_Catalog_2019	Polycystic ovary syndrome	1/47	0.5396184343010529	1.0	0	0	1.3013208406532628	0.8027757073741689	FANCC
GWAS_Catalog_2019	Intracranial aneurysm	1/47	0.5396184343010529	1.0	0	0	1.3013208406532628	0.8027757073741689	RBMS3
GWAS_Catalog_2019	Glomerular filtration rate	2/111	0.5442140922053871	1.0	0	0	1.102019450643304	0.6704824726002403	UBE2Q2;PRKAG2
GWAS_Catalog_2019	Waist-to-hip ratio adjusted for body mass index	2/111	0.5442140922053871	1.0	0	0	1.102019450643304	0.6704824726002403	SLC38A6;GPC6
GWAS_Catalog_2019	Metabolite levels	2/111	0.5442140922053871	1.0	0	0	1.102019450643304	0.6704824726002403	FEN1;ACADM
GWAS_Catalog_2019	Creatine kinase levels	1/48	0.5471633836751509	1.0	0	0	1.2742099898063202	0.7683586018235136	UBAP1
GWAS_Catalog_2019	Platelet count	6/366	0.5545217389079131	1.0	0	0	1.0026570411590716	0.59121599081301	FEN1;TBC1D5;TRPS1;DIP2B;ZFPM2;FRYL
GWAS_Catalog_2019	Endometriosis	1/49	0.5545850544289485	1.0	0	0	1.2482057043000685	0.7358610678932512	VEZT
GWAS_Catalog_2019	Allergic rhinitis	2/114	0.5586681903662142	1.0	0	0	1.0730189387842697	0.6247111532014731	RERE;AAGAB
GWAS_Catalog_2019	Alzheimer's disease (cognitive decline)	1/50	0.5618854546999639	1.0	0	0	1.2232415902140672	0.7051465041245959	GPC6
GWAS_Catalog_2019	Basophil percentage of white cells	1/50	0.5618854546999639	1.0	0	0	1.2232415902140672	0.7051465041245959	LARP4B
GWAS_Catalog_2019	Basophil percentage of granulocytes	1/51	0.5690665601044848	1.0	0	0	1.1992564609941836	0.676090273263288	LARP4B
GWAS_Catalog_2019	Parkinson's disease	3/184	0.5815787727307714	1.0	0	0	0.997207818109294	0.5404954641849374	UNC13B;VPS13C;C3ORF67
GWAS_Catalog_2019	Body mass index (age <50)	1/53	0.5830786287329798	1.0	0	0	1.15400150020195	0.6225067596144384	STK33
GWAS_Catalog_2019	Post bronchodilator FEV1/FVC ratio in COPD	1/53	0.5830786287329798	1.0	0	0	1.15400150020195	0.6225067596144384	IREB2
GWAS_Catalog_2019	Bone mineral density (hip)	1/54	0.5899133847278322	1.0	0	0	1.1326311020500623	0.5977795428762125	KIF15
GWAS_Catalog_2019	Pulmonary function (smoking interaction)	1/54	0.5899133847278322	1.0	0	0	1.1326311020500623	0.5977795428762125	GSTCD
GWAS_Catalog_2019	Serum total protein level	1/54	0.5899133847278322	1.0	0	0	1.1326311020500623	0.5977795428762125	FCHSD2
GWAS_Catalog_2019	Depression in smokers	1/54	0.5899133847278322	1.0	0	0	1.1326311020500623	0.5977795428762125	RNGTT
GWAS_Catalog_2019	Cholesterol, total	2/121	0.5911130390401861	1.0	0	0	1.0109434629868326	0.5315015163685253	TRPS1;EVI5
GWAS_Catalog_2019	Visceral adipose tissue adjusted for BMI	1/55	0.5966364325333366	1.0	0	0	1.1120378092855157	0.5743089706212283	GPATCH2
GWAS_Catalog_2019	Type 2 diabetes (age of onset)	1/56	0.6032495922714515	1.0	0	0	1.09217999126256	0.5520142533461699	HDAC9
GWAS_Catalog_2019	Refractive astigmatism	1/57	0.6097546547563949	1.0	0	0	1.0730189387842697	0.5308209754154395	NLN
GWAS_Catalog_2019	Visceral adipose tissue/subcutaneous adipose tissue ratio	1/58	0.6161533815468923	1.0	0	0	1.0545186122535062	0.5106604981812702	OPCML
GWAS_Catalog_2019	Diisocyanate-induced asthma	4/261	0.6203471388664039	1.0	0	0	0.9373498775586722	0.4475621228461489	GPD2;PRICKLE2;RAPGEF6;ARHGAP24
GWAS_Catalog_2019	Intelligence	1/59	0.6224475056055857	1.0	0	0	1.03664541543565	0.4914694267802309	KIF16B
GWAS_Catalog_2019	Albumin-globulin ratio	1/60	0.6286387317881138	1.0	0	0	1.019367991845056	0.4731891341118883	FCHSD2
GWAS_Catalog_2019	Eosinophil counts	3/199	0.6345671523846818	1.0	0	0	0.9220413996588448	0.41935564271466896	APBB1IP;RERE;PTEN
GWAS_Catalog_2019	Pulmonary function	1/61	0.6347287371698181	1.0	0	0	1.0026570411590716	0.4557653350564312	GSTCD
GWAS_Catalog_2019	Hippocampal volume in Alzheimer's disease dementia	1/61	0.6347287371698181	1.0	0	0	1.0026570411590716	0.4557653350564312	SPC25
GWAS_Catalog_2019	Granulocyte count	2/133	0.6425358149520612	1.0	0	0	0.9197305189579452	0.4068269027157833	MAST2;SPC25
GWAS_Catalog_2019	Urinary albumin excretion	1/63	0.6466116583531868	1.0	0	0	0.9708266589000534	0.4232895331424133	CWC27
GWAS_Catalog_2019	Alzheimer's disease (late onset)	1/64	0.6524077938080765	1.0	0	0	0.95565749235474	0.4081474215809677	NDUFAF6
GWAS_Catalog_2019	Axial length	1/64	0.6524077938080765	1.0	0	0	0.95565749235474	0.4081474215809677	STAU2
GWAS_Catalog_2019	Systolic blood pressure (cigarette smoking interaction)	1/66	0.6637172687422053	1.0	0	0	0.9266981744045965	0.3798526737756854	ARHGAP24
GWAS_Catalog_2019	Age-related macular degeneration	1/67	0.6692336735027848	1.0	0	0	0.912866858368707	0.36662740617427575	KCNT2
GWAS_Catalog_2019	Copper levels	1/67	0.6692336735027848	1.0	0	0	0.912866858368707	0.36662740617427575	GSTCD
GWAS_Catalog_2019	Gut microbiota (bacterial taxa)	1/67	0.6692336735027848	1.0	0	0	0.912866858368707	0.36662740617427575	MAGI3
GWAS_Catalog_2019	Logical memory (delayed recall) in normal cognition	1/67	0.6692336735027848	1.0	0	0	0.912866858368707	0.36662740617427575	PRKG1
GWAS_Catalog_2019	Lung function (FVC)	1/67	0.6692336735027848	1.0	0	0	0.912866858368707	0.36662740617427575	GSTCD
GWAS_Catalog_2019	Sum basophil neutrophil counts	2/140	0.6701080635188296	1.0	0	0	0.873743993010048	0.3497739543632127	MAST2;SPC25
GWAS_Catalog_2019	Fibrinogen levels	1/68	0.6746598584675348	1.0	0	0	0.8994423457456378	0.35397250269657665	DIP2B
GWAS_Catalog_2019	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)	1/68	0.6746598584675348	1.0	0	0	0.8994423457456378	0.35397250269657665	LYPLA1
GWAS_Catalog_2019	Crohn's disease	9/613	0.675112570855485	1.0	0	0	0.8979750662256611	0.3527926998009745	SENP7;FEN1;FCHSD2;MAGI3;KIAA1841;LNPEP;USP40;RAPGEF6;EZH2
GWAS_Catalog_2019	Mean platelet volume	4/281	0.677353971621764	1.0	0	0	0.8706345837822542	0.33916553114329634	TBC1D5;RTTN;MSI2;ZFPM2
GWAS_Catalog_2019	Neuroticism	2/142	0.6776637585641039	1.0	0	0	0.8614377395873714	0.3351889093144962	TMEM192;CSNK1G1
GWAS_Catalog_2019	Hip circumference	1/69	0.6799972946787142	1.0	0	0	0.8864069494304836	0.3418574296268707	FAF1
GWAS_Catalog_2019	Idiopathic dilated cardiomyopathy	1/69	0.6799972946787142	1.0	0	0	0.8864069494304836	0.3418574296268707	KCNT2
GWAS_Catalog_2019	Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	6/419	0.6844457960869096	1.0	0	0	0.8758293008692606	0.3320670228288743	ZEB1;RPS6KA5;COG5;LMAN2;PRICKLE2;CLOCK
GWAS_Catalog_2019	Birth weight	1/72	0.6954914656943164	1.0	0	0	0.8494733265375467	0.3084748032981415	LCORL
GWAS_Catalog_2019	Stroke	1/73	0.7004881454486156	1.0	0	0	0.8378367056260735	0.2982512976698338	HDAC9
GWAS_Catalog_2019	Chin dimples	1/74	0.7054030807546221	1.0	0	0	0.8265145879824779	0.2884419322282505	SUPT3H
GWAS_Catalog_2019	Waist circumference	1/75	0.7102376051395749	1.0	0	0	0.8154943934760449	0.2790260630419171	FANCL
GWAS_Catalog_2019	Coronary artery disease	6/433	0.7143087593858407	1.0	0	0	0.8475114943746425	0.2851367451333601	STAG1;SRFBP1;ZFPM2;HDAC9;PRKG1;WDR33
GWAS_Catalog_2019	Waist-to-hip ratio adjusted for BMI (age <50)	2/153	0.7167289656231076	1.0	0	0	0.7995043073294558	0.2662809230518648	LMAN2;PRICKLE2
GWAS_Catalog_2019	Hematocrit	2/153	0.7167289656231076	1.0	0	0	0.7995043073294558	0.2662809230518648	TRPS1;PRKAG2
GWAS_Catalog_2019	Waist-to-hip ratio adjusted for BMI	5/367	0.7196810469731768	1.0	0	0	0.8332708380204817	0.2741020718748302	ZEB1;RPS6KA5;COG5;LMAN2;PRICKLE2
GWAS_Catalog_2019	Blood metabolite levels	2/158	0.7331327918335334	1.0	0	0	0.7742035381101692	0.2403347899074383	ACADM;SGPP1
GWAS_Catalog_2019	Granulocyte percentage of myeloid white cells	2/159	0.7363152224185883	1.0	0	0	0.7693343334679669	0.2354909011707033	TRPS1;POC1B
GWAS_Catalog_2019	Mean arterial pressure x alcohol consumption interaction (2df test)	1/81	0.7376280936030352	1.0	0	0	0.7550874013667082	0.22978481489671726	POC1B
GWAS_Catalog_2019	Red blood cell traits	1/82	0.7419352944222001	1.0	0	0	0.7458790184232118	0.22263984776610754	PRKAG2
GWAS_Catalog_2019	Venous thromboembolism adjusted for sickle cell variant rs77121243-T	1/86	0.7584705427245363	1.0	0	0	0.7111869710546903	0.19660857490300496	OPCML
GWAS_Catalog_2019	Inflammatory skin disease	1/93	0.7849057803460623	1.0	0	0	0.6576567689322943	0.1592789408044281	ABHD5
GWAS_Catalog_2019	Chronic inflammatory diseases (pleiotropy)	2/177	0.7882753204022466	1.0	0	0	0.6910969436237668	0.1644173940626486	RIC8B;SKAP2
GWAS_Catalog_2019	Alopecia areata	1/94	0.7884389747142118	1.0	0	0	0.6506604203266315	0.1546621574092264	MAGI3
GWAS_Catalog_2019	Coronary artery disease (myocardial infarction, PTCA, CABG, angina or CIHD)	1/94	0.7884389747142118	1.0	0	0	0.6506604203266315	0.1546621574092264	HDAC9
GWAS_Catalog_2019	Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)	1/94	0.7884389747142118	1.0	0	0	0.6506604203266315	0.1546621574092264	POC1B
GWAS_Catalog_2019	Menopause (age at onset)	1/94	0.7884389747142118	1.0	0	0	0.6506604203266315	0.1546621574092264	POLG
GWAS_Catalog_2019	Autism spectrum disorder or schizophrenia	10/752	0.7897364018781312	1.0	0	0	0.8133255254082894	0.1919904171623784	RERE;STAG1;IMMP2L;FAM13B;FANCL;IREB2;TAP2;ZSCAN23;VRK2;PRKG1
GWAS_Catalog_2019	Mosquito bite size	1/95	0.7919143059216917	1.0	0	0	0.6438113632705618	0.15020253830068128	RAPGEF6
GWAS_Catalog_2019	Systolic blood pressure x smoking status (ever vs never) interaction (2df test)	1/96	0.795332718748077	1.0	0	0	0.6371049949031601	0.14589369121553245	POC1B
GWAS_Catalog_2019	Total cholesterol levels	2/190	0.8199963286635737	1.0	0	0	0.6438113632705618	0.1277678519062645	TRPS1;EVI5
GWAS_Catalog_2019	Triglyceride levels	1/104	0.8207393695248113	1.0	0	0	0.5880969183721477	0.11617835499410188	RIC8B
GWAS_Catalog_2019	Bipolar disorder	2/194	0.8288652682381114	1.0	0	0	0.6305369021721996	0.11835030126439232	FEN1;C11ORF80
GWAS_Catalog_2019	Body mass index x sex x age interaction (4df test)	1/109	0.83499544869014	1.0	0	0	0.5611199955110401	0.1011862103732164	STK33
GWAS_Catalog_2019	Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)	1/109	0.83499544869014	1.0	0	0	0.5611199955110401	0.1011862103732164	POC1B
GWAS_Catalog_2019	Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)	1/112	0.8430005376116647	1.0	0	0	0.54608999563128	0.09326544519671684	POC1B
GWAS_Catalog_2019	Mean corpuscular volume	4/365	0.8505606079252437	1.0	0	0	0.6702693645008588	0.1084895367012908	SPECC1;AGAP1;ATR;MIPOL1
GWAS_Catalog_2019	Systolic blood pressure x alcohol consumption interaction (2df test)	1/115	0.8506183897670526	1.0	0	0	0.5318441696582902	0.08604795991876188	POC1B
GWAS_Catalog_2019	Intelligence (MTAG)	4/366	0.8520312490730014	1.0	0	0	0.6684380274393811	0.10703836868347004	SYT1;GPD2;FBXL17;TTC27
GWAS_Catalog_2019	Vitiligo	1/121	0.8647661952391555	1.0	0	0	0.5054717314934163	0.07344307281705115	RERE
GWAS_Catalog_2019	Lung adenocarcinoma	1/123	0.8691787172577207	1.0	0	0	0.4972526789488079	0.06971806585472298	NAF1
GWAS_Catalog_2019	General cognitive ability	3/299	0.8697204451067284	1.0	0	0	0.6136663496057194	0.08565766403839678	SYT1;GPD2;CEP192
GWAS_Catalog_2019	Psoriasis	1/127	0.8775777619528379	1.0	0	0	0.4815911772496328	0.06289085215553131	PTEN
GWAS_Catalog_2019	Acne (severe)	2/223	0.8822241569650215	1.0	0	0	0.5485388296924069	0.06873691202598976	DOCK2;KIF15
GWAS_Catalog_2019	Pancreatic cancer	1/130	0.883522260737038	1.0	0	0	0.4704775346977182	0.058263369305761786	TTC28
GWAS_Catalog_2019	Celiac disease	1/130	0.883522260737038	1.0	0	0	0.4704775346977182	0.058263369305761786	UBE2E3
GWAS_Catalog_2019	Sum neutrophil eosinophil counts	1/133	0.889178945048325	1.0	0	0	0.4598652594789726	0.05401429063741199	SPC25
GWAS_Catalog_2019	Red cell distribution width	2/230	0.8925717342346963	1.0	0	0	0.5318441696582902	0.060443235774786615	DIP2B;ATR
GWAS_Catalog_2019	HDL cholesterol	2/238	0.903362638921572	1.0	0	0	0.5139670547117929	0.052235095054157486	STAG1;TRPS1
GWAS_Catalog_2019	Multiple sclerosis	2/244	0.9107838138225988	1.0	0	0	0.5013285205795358	0.04684900803900486	SAMD12;EVI5
GWAS_Catalog_2019	Rheumatoid arthritis	1/182	0.950906671784721	1.0	0	0	0.3360553819269416	0.01691681223815351	RTKN2
GWAS_Catalog_2019	Breast cancer	1/219	0.9734879445607592	1.0	0	0	0.2792789018753578	0.007504178808687617	FAM126B
GWAS_Catalog_2019	Ulcerative colitis	3/456	0.9807219597518849	1.0	0	0	0.4023821020441011	0.007832884644574474	GPD2;RAPGEF6;HDAC9
GWAS_Catalog_2019	Waist-to-hip ratio adjusted for BMI (age >50)	1/250	0.9841919150693109	1.0	0	0	0.24464831804281345	0.003898315671515015	PRICKLE2
GWAS_Catalog_2019	Inflammatory bowel disease	5/709	0.9912271873935656	1.0	0	0	0.4313263717256937	0.003800641070316243	SENP7;KIAA1841;LNPEP;RAPGEF6;EZH2
GWAS_Catalog_2019	Blood protein levels	16/2091	0.9999040445906628	1.0	0	0	0.4680025213635839	4.490952819880474e-05	NTNG1;CALCOCO2;FUT10;MAST2;TAP2;KIAA1549L;LNPEP;FUT8;KCNT2;LMAN2;ADAM23;ZSCAN23;POC1B;ARFIP1;POC1B-GALNT4;ZFPM2
